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Cryptosporidium species are eukaryotic intracellular parasites belonging to the 
phylum Apicomplexa.  C. hominis and C. parvum cause diarrhea in humans which is 
self-limiting in immunocompetent adults but can have severe consequences in 
immunocompromised individuals and malnourished children.  In developing countries, 
Cryptosporidium is one of the leading causes of moderate to severe diarrhea in children 
under five years of age.  There is an urgent need for novel therapeutics against this 
parasite as the current treatment option is inadequate to treat the most vulnerable 
population to Cryptosporidium infection. Better understandings of the biology of 
Cryptosporidium would greatly enhance our capability to design effective control 
measures.  
The parasite initially multiplies through several rounds of asexual replication 
within the intestinal epithelial cells before differentiating into sexual forms.  Here we 
have tested the ReFRAME library, a set of ~12,000 biologically active compounds, for 
activities against the asexual and sexual forms of C. parvum separately. We identified 
and validated compounds that inhibit and/or induce the growth of either or both life 
cycle stages.  Compounds that inhibit both stages are potentially good drug candidates. 
Other compounds have promising tool-like properties that can be utilized to probe 
different aspects of C. parvum sexual differentiation. Several inhibitors of host cell 
oxidative phosphorylation and purine nucleotide biosynthesis disproportionately 
inhibited the sexual differentiation of C. parvum, highlighting the necessity of these 
processes in facilitating C. parvum sexual differentiation.   
All the apicomplexan parasites differentiate into distinct forms in the course of 
their life cycle and each of the differentiation steps is associated with large scale 
changes in gene expression.  To identify such stage specific genes and pathways 
associated with C. parvum sexual differentiation, we performed mRNA-seq of host 
cells infected with C. parvum in the presence of nine differentiation inhibitors.  
Ribosomal proteins were the most significantly enriched group of genes that were 
upregulated with multiple differentiation inhibitors, which suggested that the 
downregulation of these genes is associated with C. parvum sexual differentiation.  
Comparison of our results with a publicly available stage-specific mRNA-seq dataset of 
C. parvum validated this conclusion and analysis of transcriptomic datasets from other 
apicomplexan parasites revealed that this is a common mechanism of regulating life 
cycle stage differentiation in these parasites.  In addition, identification of significantly 
enriched DNA motifs at promoters of dysregulated genes coupled with the expression 
pattern of several apicomplexan AP2 transcription factors strongly suggested that they 
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CHAPTER 1:  A REVIEW OF THE MECHANISMS THAT REGULATE 
STAGE DIFFERENTIATION DURING THE LIFE CYCLE PROGRESSION 
OF APICOMPLEXAN PARASITES 
 
1.1:  Purpose of this Review 
The major goal of this thesis was to identify mechanisms underlying 
differentiation of the apicomplexan parasite Cryptosporidium.  For this, we relied 
heavily on the main strengths of our laboratory, which are in the areas of high 
throughput assay development and drug screening.  We describe development of a 
microscopy-based screening assay for asexual to sexual stage development of 
Cryptosporidium, its use to screen a library of biologically active small molecules, and 
then follow up studies to characterize the effects of identified inhibitors using RNA-
seq.  This literature review chapter provides background on parasites related to 
Cryptosporidium within the phylum Apicomplexa, what is known about differentiation 
of major apicomplexan parasites, and general themes that have emerged from prior 
research on apicomplexan differentiation.    
 
1.2:  Origin and Classification of Apicomplexan Parasites 
Apicomplexa is a phylum of unicellular eukaryotes that are obligate 
intracellular parasites.  The defining characteristic of this phylum is that they all harbor 
an apical complex, a structure composed of specialized organelles and cytoskeletal 
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structures, during at least one stage of their life cycle.  It is present at the anterior end of 
the parasite and is required to invade the host cell.  Apicomplexans infect almost all 
vertebrates and invertebrates and the host specificity of each species is relatively 
restricted, with some notable exceptions (1-3).  
Another feature of apicomplexans beside the apical complex is the apicoplast, a 
non-photosynthetic plastid, that is present in most of the apicomplexan parasites.  The 
apicoplast genome has given us major clues about the origin and evolution of 
apicomplexans.  The four membrane enclosure of the apicoplast suggests a secondary 
endosymbiotic origin of the organelle (4).  Such an organelle is, however, not 
completely unique in apicomplexans.  Around half of the members of Dinoflagellata, a 
sister phylum of Apicomplexa consisting of unicellular planktons, are among the other 
groups of organisms that contain a secondary endosymbiotic plastid (4).  Interestingly, 
even though phylogenetic analysis of plastid rRNAs shows that apicomplexan and 
dinoflagellate plastids came from the same origin, their gene sets do not overlap a lot 
(5).  Discovery of the unicellular photosynthetic organisms Chromera velia and Vitrella 
brassicaformis provided the missing link between apicomplexans and dinoflagellates 
(6, 7).  Both of them have a secondary endosymbiotic plastid that encode a superset of 
genes present in the plastids of apicomplexans and dinoflagellates.  Phylogenetic 
analysis of their plastid genome reinforced the already widely supported notion that 
their plastid, just like the plastids of apicomplexans and dinoflagellates, originated from 
red algal plastids (6).  Phylogenetic trees constructed using the 18S rRNA and nuclear 
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genes also point towards a common ancestor of apicomplexans, dinoflagellates and 
chrompodellids (Chromera velia, Vitrella brassicaformis, and other related genera) (8, 
9).  Therefore, the currently held view is that the common ancestor of all three above 
mentioned groups was a free-living photosynthetic unicellular eukaryote with a 
secondary endosymbiotic plastid of red algal origin.  Subsequent evolution of this 
ancestor gave rise to several lines, some keeping the photosynthetic capability while 
apicomplexans lost it (10, 11).  Importantly, there are groups of organisms in different 
lineages originating from this ancestor that have also completely lost the plastid (9). 
Transfer of genes between organelle genome and nuclear genome, termed 
endosymbiotic gene transfer, is very common in eukaryotes, including apicomplexans 
(12, 13).  A class of transcription factors (TFs), the Apetala 2 (AP2) domain-containing 
TFs, exemplify such a mode of gene transfer between apicoplast and nuclear genome. 
Several apicomplexans severely lack common TF families normally present in animal 
cells (14).  In silico identification of DNA binding proteins followed by searching their 
homologs in all life forms identified that several apicomplexan DNA binding proteins 
share homology to plant Apetala 2 domain-containing transcription factors (14).  The 
apicomplexan orthologues are named Apicomplexan AP2 (ApiAP2) TFs. Genomes of 
all apicomplexans, as well as their apicoplast bearing cousins sequenced so far, have 
this family of TFs in their genome, some more than the others (14, 15).  This suggests 
that after an initial endosymbiotic transfer, this family of TFs later expanded in a 
lineage-specific manner (14).  The role of ApiAP2 TFs in apicomplexan gene 
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regulation has been studied extensively and several of them play key regulatory roles in 
the progression of the apicomplexan life cycle. 
Apicomplexans can be broadly divided into four different groups based on 
phylogenetic analyses, structural features and host range (1, 2, 16, 17).  The most 
understudied among them are the gregarines, which are parasites of invertebrates.  
Advances in environmental DNA sequencing are slowly unearthing an abundance of 
gregarine parasites in diverse environments; however, molecular characterization of the 
members of this group is scarce (8, 18, 19).   Phylogenetically, gregarines are difficult 
to group together among themselves, leading to them being called deep-branching 
apicomplexans (8, 9).  The apicoplast is presumed to be lost in many gregarines (9).  
Members of the sole genus Cryptosporidium constitutes the second major group of 
apicomplexans.  These are parasites of the vertebrate gastrointestinal tract.  None of the 
Cryptosporidium species harbors an apicoplast and they have also lost a fully functional 
mitochondrion.  Instead, they have a mitochondrion-like organelle called a mitosome 
that lacks its own genome.  Several nuclear-encoded genes are nonetheless targeted to 
this relict mitochondrion and its primary function seems to be Fe-S cluster generation 
(20-22).  Until recently, Cryptosporidium species were considered to be members of 
another major apicomplexan group called the coccidians (17).  Coccidians are parasites 
of both vertebrates and invertebrates.  Their similarity to Cryptosporidium is that they 
produce cysts that are the infective form of the parasite.  However, unlike 
Cryptosporidium, they have functional apicoplasts and mitochondria.  Coccidians are 
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very diverse in their host range; some of them are specific for certain host species, 
while others have a broader host range (23, 24).  The most well-studied coccidian 
parasite is Toxoplasma gondii, which is often used as a model apicomplexan due to the 
availability of well-established genetic manipulation systems for this parasite.  Finally, 
the other group of apicomplexans, haematozoa, are parasites of the vertebrate 
circulatory system that are transmitted by blood-sucking insect vectors.  The insect 
vectors are the definitive hosts of this group of parasites, as sexual replication occurs 
within them, while vertebrates are intermediate hosts where they replicate asexually.  
The apical complex of haematozoans lacks a conoid, a special arrangement of 
microtubules, that is present in the apical complex of all the other groups of 
apicomplexan parasites (25, 26).  Plasmodium parasites, the causative agents of 
malaria, belong to this group.  
 
1.3:  Significance of the Research on Apicomplexan Stage Differentiation and 
Scope of this Review 
One of the common aspects of the life cycle of all the apicomplexan parasites is 
that they differentiate into distinct forms at various stages of their life cycle.  All of 
them have at least three different forms, namely, sporozoites, asexual replicative forms, 
and sexual replicative forms.  The term for asexual replicative forms varies by species.  
There is no sex chromosome in apicomplexans, but mature gametes are dimorphic.  
Most commonly, one gamete is comparatively larger than the other gamete, which is 
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called the macrogamete or the female gamete. The comparatively smaller gamete, 
which is usually formed from a gametocyte containing multiples of them, is called the 
microgamete or male gamete.  A gamete within a host cell is called a gametocyte.  
Additionally, based on the species, they take other special forms through the 
progression of their life cycle.   
Apicomplexan differentiation has been an active area of research.  The fact that 
each of these unicellular intracellular parasites can transform into very different forms 
characterized by altered structures and phenotypic characteristics, as well as different 
modes of replication and metabolism, while maintaining essentially the same genetic 
makeup makes apicomplexan parasites ideal candidates to study the regulation of gene 
expression and basic cell biology.  From an evolutionary and ecological perspective, 
how apicomplexans survive in diverse conditions and each establishes its own 
ecological niche are of huge interest.  
Several apicomplexans cause significant diseases in humans that are of major 
public health and economic concern.  Plasmodium parasites cause malaria, which still 
kills thousands of people every year.  Blocking Plasmodium differentiation in people is 
central to transmission-blocking strategies (27).  Around one third of the population in 
the world are thought to be chronically infected with T. gondii gondii, an opportunistic 
pathogen of humans.  The secret behind this astonishingly high prevalence is its ability 
to differentiate into a cyst form, which is untreatable with the current therapeutics (28).  
Cryptosporidium has recently been identified as one of the major causes of childhood 
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diarrhea in the developing world (29).  There is no efficacious therapeutic available for 
Cryptosporidium infection of immunocompromised patients and malnourished 
children, the two most vulnerable populations to Cryptosporidium infection (30).  Our 
current understanding of Cryptosporidium biology suggests that blocking 
differentiation would be an effective therapeutic strategy against this parasite.   
Early development of apicomplexan parasites within the human body involves 
differentiation from the environmentally resistant form or vector transmissive form to a 
more human adopted form capable of establishing an infection.  Each of the pathogenic 
Apicomplexa subsequently differentiate further to rapidly replicating forms that are 
more associated with the pathologies of the diseases they cause. While inhibiting the 
later stages are straightforward strategies in drug development, understanding the early 
stages are more important towards vaccine development.  Development of attenuated 
strains incapable of early differentiation as well as using early stage-specific cell 
surface markers as subunit vaccines are two of the most common strategies employed 
in anti-apicomplexan vaccine development (31, 32).  
Unsurprisingly, detailed studies on the molecular mechanism of differentiation 
have been mainly performed on apicomplexan genera that are pathogens of human or 
economically important pathogens of livestock and poultry.  In this review, we will 
discuss the differentiation of three haematozoans (Plasmodium, Babesia, Theileria), 
two coccidians (T. gondii and Eimeria) and the sole genus of the group 
Cryptosporidium.  Notable pathogens that are not discussed due to relative scarcity of 
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differentiation-related literature include two coccidian parasites, the human pathogen 
Cyclospora and the livestock pathogen Neospora.  No gregarine parasite has been 
discussed, as their molecular mechanism of differentiation has not been studied yet 
(33).  
A key aspect of the apicomplexan differentiation processes is the extensive 
change in the global gene expression pattern associated with differentiation.  Emphasis 
has been given in this review about characterizing these global changes, as well as key 
components that play master regulatory roles in bringing about these changes.  
However, numerous studies have also been performed to understand the structures and 
functions of components that have roles in the developmental progression of each of 
the distinct differentiated stages.  Several comprehensive reviews have been published 
discussing such components for a particular stage of each of the parasites’ life cycles.  
Instead of repeating the same information in this review, we have referred to those 
articles wherever appropriate.       
 
1.4:  Plasmodium Stage Differentiation 
Plasmodium parasites are the causative agents of malaria, which killed more 
than 400 thousand people in 2018.  Vertebrates are the intermediate hosts and 
mosquitos are the definitive hosts of Plasmodium species.  Six Plasmodium species 
infect humans, among them P. falciparum is the most well-studied species. Several 
simian, avian and rodent Plasmodium species are used as model organisms in 
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laboratory settings to understand its biology (34).  Notable among them are the rodent 
parasites P. berghei and P. yoelii. Continuous in vitro cultivation of several species of 
Plasmodium is performed within red blood cells (RBCs) (35).  
1.4.1:  Sporozoite to Liver Stage Differentiation  
Sporozoites, the form of Plasmodium parasites that initiates infection of the 
vertebrate host, encounter the most diverse conditions among all the life cycle stages of 
Plasmodium (Figure 1).  They are developed inside oocysts residing at basal lamina of 
the mosquito midgut, and after egressing from the oocyst, they travel via hemolymph to 
the mosquito salivary gland and invade it.  Salivary gland sporozoites are inoculated 
into vertebrate skin during a mosquito bite, traverse the dermis to gain entry into the 
blood circulation, and then, in mammalian hosts, sporozoites again traverse the 
endothelial cells in liver sinusoids to access hepatocytes where they can start the 
exoerythrocytic phase of the infection (36, 37).  It is not surprising that sporozoites at 
different stages of this process differ from each other.  Many Plasmodium genes have 
been identified that are essential for a specific part of the sporozoite’s life while 
dispensable for the others.  It suggests a model of stepwise maturation of sporozoites 
capable of establishing infection in the liver (36, 37).   
Interestingly, commitment to the exoerythrocytic phase seems to be attained 
even before the sporozoites contact the vertebrate host.  First shown in the rodent 
parasite Plasmodium berghei, sporozoites from the salivary gland are 10,000 times 
more infectious to the mammalian host than sporozoites from oocysts (38).  The same 
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phenomenon was subsequently shown in several other Plasmodium species, and, with 
the avian parasite P. gallenaceum, it was shown that salivary gland sporozoites lose 
infectivity for the mosquito salivary gland once they were reintroduced into the 
mosquito hemocoel (39).  Sporozoites in the hemolymph show intermediate infectivity 
and other intermediate phenotypic characteristics that fall between the characteristics of 
salivary gland sporozoites and oocyst sporozoites (40).   
Comparative transcriptomics and proteomics analyses between oocyst 
sporozoites and salivary gland sporozoites to determine the regulation of this 
commitment have identified multiple genes upregulated in one population compared to 
others (41-44).  Knockout of several of the genes upregulated in infectious sporozoites 
(UIS) formed parasites that are capable of infecting hepatocytes, but then fail to 
successfully replicate inside them (45-49).  The most studied among them, which has 
often been used as a marker for salivary gland oocyst and liver stage Plasmodium, is 
UIS4 (45).  UIS4 regulation in sporozoites and  liver stage Plasmodium provides 
important mechanistic details about Plasmodium sporozoite to  liver stage 
differentiation (45).  Even though UIS4 mRNA is highly expressed in salivary gland 
sporozoites, it is post-transcriptionally repressed in sporozoites and the protein level 
eventually goes up in the liver stage (50).  The RNA binding protein Puf2 binds to the 
UIS4 transcript and keeps it in a repressed state (51).  Puf2 knockout sporozoites reach 
the salivary gland, but cannot infect the liver (47, 48, 52).  This mutant also 
differentiates into a form that resembles early  liver stage Plasmodium while still 
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residing in the mosquito salivary gland (47, 48, 52).   
Several studies suggest that this transcriptionally active but translationally 
repressed state is not a unique feature of UIS4, and that this is a general strategy of 
Plasmodium to be prepared for infection upon switching hosts (44, 48, 53, 54).  Indeed, 
the kinase IK2 that phosphorylates and inactivates translation initiation factor eIF2α has 
been shown to be an important regulator of this process in Plasmodium (54).  IK2 
knockout parasites showed reduced phosphorylation of eIF2α and an overall 
upregulated protein translation, including translation of UIS4, in sporozoites (54).  
Phenotypically, the IK2 knockout mutant also prematurely develops into a  liver stage 
like form (54).  Translationally repressed UIS mRNAs, including UIS4, are actively 
protected from degradation in salivary gland sporozoites, and a Plasmodium protein 
called SAP is involved in that process (49).  Like the other mutants mentioned before, 
SAP knockout also inhibits liver stage development (49).   
Recently, RNA-seq based transcriptomics, quantitative proteomics, and high 
throughput screening of knockout mutant libraries have verified some of those earlier 
findings, while also generating a clearer landscape of metabolic changes during 
differentiation (55-58).  For example, a mutant library screening demonstrated 
essentiality of the type II fatty acid biosynthetic pathway in liver stage development 
(58).  Some of the members in this pathway are upregulated in salivary gland 
sporozoites, and were previously shown to be essential in parasite development into the 
liver stage (59, 60).  Another study performed comparative RNA-seq and proteomics 
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analyses of oocyst sporozoites and salivary gland sporozoites of both P. yoelii and P. 
falciparum, and validated the translational repression program in salivary gland 
sporozoites (57).  Interestingly, this study also suggests an independent translational 
repression program in oocyst sporozoites that is released after sporozoite invasion of 
the salivary gland (57).  This might be the explanation for the inability of salivary gland 
sporozoites to reinfect the salivary gland as mentioned before (39).  Follow up genetic 
experiments based on these high throughput sequencing analyses (57) would likely help 
in identifying genes and pathways critical for differentiation.   
The stimulus for sporozoite to  liver stage differentiation has been suggested to 
be dependent on time (i.e. after a certain time, a sporozoite is committed to 
differentiation) and space (i.e. the environment around a sporozoite determines its stage 
of commitment); however, no definite molecular signal has been established yet.  In 
terms of a transcriptional regulator, AP2-L is an AP2 transcription factor that is 
necessary for liver-stage development (61-63).  AP2-L protein is expressed in blood 
stage, sporozoite and liver-stage P. berghei, but the AP2-L knockout mutant showed 
complete developmental arrest only in Liver stage (61).  Knockout mutants of three 
other AP2 TFs in P. berghei failed to form sporozoites from oocysts, or the sporozoites 
failed to reach the salivary gland (62-64).  Detailed identification and characterization 
of the targets of these transcription factors would likely provide more information about 




1.4.2:  Liver Stage to Erythrocytic Stage Differentiation    
The exoerythrocytic cycle for mammalian Plasmodium species takes place 
within hepatic cells (Figure 1).  A sporozoite first transforms into a trophozoite, which 
then replicates into thousands of merozoites within a single hepatic cell.  Packets of 
merozoites called merosomes bud out from the hepatic cells into the blood, and are 
ultimately released to start the erythrocytic cycle of Plasmodium infection (65, 66).  
Numerous individual proteins are implicated at different stages of this development 
process through single-gene knockout studies (nicely summarized in Table 1 of (67)).  
However, identification of master regulatory elements involved in exoerythrocytic to 
erythrocytic stage differentiation is still absent.  One potential reason for this is the 
scarcity of transcriptomic and proteomics data in high enough temporal or phenotypic 
resolution as to differentiate different stages of the exoerythrocytic phase.  Fortunately, 
such experiments are starting to come out (55, 56).  Another reason that is likely 
hampering the characterization of master regulatory elements is the standard genetic 
manipulation system of Plasmodium.  The erythrocytic phase parasite has largely been 
the starting point of genetic modification and clonal selection in Plasmodium (68).  As 
such, essential genes for erythrocytic growth are not suitable for straight knockout.  The 
liver stage directly precedes the erythrocytic phase, and it is highly likely that factors 
involved in differentiation from liver stage to the erythrocytic stage are also essential 
during erythrocytic schizogony.  In addition, knockout of any gene that is also essential 
in the sexual and/or sporozoite stage would never produce viable liver stage 
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Plasmodium. Therefore, targeted analysis of any gene function in liver stage 
Plasmodium with the aid of a knockout mutant of that gene would only be possible if 
the gene is not essential in any other stages of the Plasmodium life cycle.  The 
development of several conditional knockout systems in Plasmodium has huge 
potential to overcome this limitation (69, 70).   
Several Plasmodium species, including the human pathogen P. vivax, 
differentiate into a latent form termed a hypnozoite after infecting liver cells (71).  A 
hypnozoite culture system and omics data have just started to emerge in the past few 
years (72-74), but the induction and relapse mechanism is still largely unknown.  
1.4.3:  Sexual Differentiation of Plasmodium 
Plasmodium sexual differentiation is one of the most heavily studied 
differentiation processes among apicomplexans.  The merozoites from the liver infect 
RBCs to start the erythrocytic cycle of Plasmodium infection.  Upon infection, the 
parasite takes on a flat disk-like morphology called a ring phase, then it rounds up to 
form a trophozoite, which then replicates multiple times through erythrocytic 
schizogony to produce up to 32 merozoites that are released into the blood after RBC 
rupture.  The merozoites start another cycle of RBC infection, and either repeat the 
asexual cycle again or develop into gametocytes.  RBCs enclosing mature gametocytes 
circulate in the bloodstream until taken up by a mosquito (Figure 1).  
Gametocytogenesis, the process of developing mature gametocytes, takes 24 to 60 
hours in most Plasmodium species and 9 to 12 days for P. falciparum (34, 75).  
  
15 
Interestingly, the commitment to gametocytogenesis occurs one schizogony 
cycle before the ultimate gametocytogenesis.  Seminal experiments, first with Giemsa 
staining and then with stage-specific antibody staining of Plasmodium on RBC 
monolayers demonstrated that all the progeny merozoites from a single schizont either 
develop into gametocytes or asexual merozoites (76, 77).  Therefore, even though the 
schizonts are morphologically indistinguishable, they are already committed to form 
either sexual or asexual forms.  Subsequently, using gender-specific antibody staining, 
it was shown that a sexually committed schizont gives rise to either male or female 
gametocytes exclusively (78, 79).   
Several laboratory clones of Plasmodium do not form gametocytes.  
Comparative genomic analysis of these clones followed by targeted gene knockouts 
identified two master regulators of this commitment, AP2-G and GDV-1 (80-82).  AP2-
G, a member of the AP2 transcription factor family, is expressed in the sexually 
committed schizonts and acts as a transcriptional activator for several early gametocyte 
genes (81, 82).  In P. falciparum, the expression of AP2-G itself is under the control of 
heterochromatin protein 1 (HP-1), which epigenetically represses the expression of 
AP2-G by binding at the ap2g locus (83).  GDV-1 has been shown to interact and evict 
HP-1, and thus release the transcriptional repression of AP2-G (84).   This puts GDV-1 
upstream to AP2-G in terms of gametocytogenesis regulation.  This epigenetic mode of 
gametocytogenesis control is well supported by other studies.  For example, several 
histone post-transcriptional modifications are exclusively enriched during 
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gametocytogenesis (85), and several epigenetic modifiers selectively inhibit the sexual 
and asexual stages of Plasmodium (86).  
A forward genetic approach using piggyBac transposon mutagenesis identified 
16 genes essential for gametocytogenesis (87).  Targeted analysis of AP2 gene family 
members in P.   berghei showed that knockout of AP2-G2, a transcriptional repressor, 
results in a developmental arrest of gametocytes following commitment (88), and 
knockout of AP2-FM, potentially a transcriptional activator, results solely in a failure 
of female gametocyte development (89).   
Comparative genomics, mutant library screening and targeted mutagenesis 
approaches led to the identification of several other Plasmodium genes that have roles 
in general gametocytogenesis, as well as male and female gametocyte production 
(Table 1 in (90), (34)). However, comparative transcriptomics is arguably a more 
powerful tool to understand the dynamic genetic regulation of the differentiation 
process.  Microarray analysis of tightly controlled timepoints has revealed a picture of 
cyclic changes in the gene expression pattern in Plasmodium during erythrocytic 
schizogony (91).  However, similar transcriptomic or proteomic comparison between 
sexual and asexual stages of Plasmodium is challenging, because gametocytogenesis is 
a rare event during the erythrocytic replication stage of Plasmodium, which makes it 
difficult to capture clean ‘-omics’ data from gametocytes using simple time point 
resolutions  (92, 93).  This challenge has been partially met by FAC (Fluorescent 
activated cell) sorting transgenic parasites expressing fluorescent proteins under male 
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or female specific promoters (94-96).  It allowed the identification of male and female 
specific proteins and pathways in Plasmodium (94-96).  However, male and female 
gametocytes are comparatively late stages of the gametocytogenesis process in which 
the sexual conversion has already taken place.  But as mentioned before, the 
commitment to those stages occurs earlier in a sexual/asexual indistinguishable 
schizont stage.   
There is still no clean early sexually committed schizont marker.  Single cell 
transcriptomics has proven to be a particularly well suited technique to address this 
challenge, as it allows the analysis of transcriptome from rare cell populations.  The 
first single cell transcriptomic experiment focusing on sexually committed schizonts 
identified, among other things, two additional AP2 transcription factors and four 
chromatin modifiers differentially upregulated in sexually committed schizonts, 
reaffirming the role of AP2 TFs and epigenetics in Plasmodium sexual commitment 
(97).  It also described a more detailed expression pattern of AP2-G.  AP2-G is 
expressed in a low level in both early sexually and asexually committed schizonts. 
Following a trough in expression in both populations, it is expressed highly only in 
mature sexually committed schizonts (97).  Since then, other studies have used this 
technique to characterize the early stages of gametogenesis, and implications and 
validation of their findings would surely paint a clearer picture of sexual commitment 
in Plasmodium (84, 98).  Importantly, one of them reported that gametocytogenesis can 
happen without a committed schizont stage, which results in the formation of mixed 
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plaques containing both sexual and asexual merozoites, questioning the decade-old 
standard theory of gametocytogenesis commitment (98).  The proposed theory behind 
this mechanism is in line with the detailed temporal AP2-G expression pattern 
mentioned before.  The study proposes that in early schizonts, if AP2-G expression 
reaches a threshold, it allows AP2-G to express again in mature schizonts, committing 
them to gametogenesis.  In support of this theory, they showed that artificial AP2-G 
stabilization during schizogony can induce gametogenesis without going through a 
committed schizogony cycle (98).   
Stress on both host and parasite has long been considered to be a major signal 
for gametocytogenesis (99).  This belief radiates from the observation that high doses 
of anti Plasmodium drugs increase the rate of sexual conversion (100) and that P. 
falciparum gametocytes are preferentially developed in reticulocytes, which are 
immature erythrocytes that are more readily available in anemic blood (101, 102).  
Based on several empirical datasets that analysed the relationship between stress and 
Plasmodium sexual conversion, a model proposed that reducing gametocyte conversion 
during low levels of stress actually increase the chance of future successful 
transmission whereas under highly stressed condition, the parasite allot more resources 
to gametocytogenesis as a way of terminal investment for successful transmission.  
High drug pressure is such a stress condition for the parasite when mortlity rate exceeds 
the parasite proliferation rate or severe anaemia is such a stress condition of the host 
when the mortality is imminent (99).    Recently, depletion of a serum factor called 
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lysoPC has been shown to be a signal for gametocytogenesis in P. falciparum but not in 
P. berghei (103).  The relationship of this molecule to stress is unclear.  In any case, 
this aspect of gametocytogenesis requires further focus.  
1.4.4:  Sex-specific Maturation for Differentiation into Zygote 
The gametocytes are taken up by the mosquito during a blood meal.  In the 
mosquito midgut, gametocytes are activated to form gametes, actively come out of the 
RBC, and mate to form the zygote (Figure 1).  Gamete activation or gametogenesis 
involves rounding up of the gametocyte, disrupting the RBC membrane, and the egress 
of mature gametes in the mosquito midgut.  Change of temperature and pH from 
mammalian blood to mosquito midgut, as well as the mosquito derived factor 
xanthurenic acid, act as signals for gametogenesis (104, 105).  A meiotic nuclear 
division without diakinesis occurs within three hours of zygote formation, and the 
diploid zygote transforms into a motile tetraploid ookinete (106). The ookinete 
traverses the mosquito midgut epithelium to reach the basal lamina, transforms into an 
immotile oocyst, and multiple haploid sporozoites are formed.  The initial stages in the 
mosquito vector are quite rapid; within 15 minutes the gametes come out, and the 
zygotes are formed within two hours in the mosquito midgut.  Ookinete development 
takes 20 h to 35 h, and the oocyst development is a long process, taking around 10 to 12 
days (107).   
Two distinct maturation programs run in parallel in male and female 
gametocytes, culminating in male and female gamete formation at the same time and 
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space.  Multiple proteins have been characterized that are expressed differentially in 
male and female gametocytes and are essential at different stages of development of 
Plasmodium gametocytes in a sex-specific manner.  Knockout of these genes usually 
results in a deficiency in gametocyte maturation/ gamete activation/ zygote formation/ 
ookinete conversion or dysfunctional ookinete formation (Table 1 in (107), (108-110)).  
Indeed, global transcriptomic and proteomic comparisons of male and female 
gametocytes uncover distinct expression profiles for them that are shaped by their 
distinct needs (94-96).  For example, upon activation, a male gametocyte divides 
mitotically three times to produce eight microgametes.  The motile microgametes lyse 
and egress from the RBC in a distinct fashion called exflagellation. The formation and 
motility of microgametes require assembly of an axoneme, a microtubule-based 
structure.  The transcriptome and proteome of male gametocytes are overwhelmingly 
enriched for DNA replication and axoneme formation machinery compared to the 
female gametocyte (94, 96).  On the other hand, the cytoplasm of zygote and early 
ookinete is derived from female gamete, as the smaller male gametes mostly only 
supply a copy of the genome to the female gamete during fertilization.  The zygote and 
early ookinete express a lot of new proteins, which is a hallmark of the stage 
conversion (111, 112).  To support this rapid transformation, a lot of cellular energy is 
also required.  In line with this point of view, the female gametocyte transcriptome and 
proteome are enriched for pathways of protein synthesis and degradation, as well as 
energy metabolism (94-96).   
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The phenomenon of “just in time” expression observed for the mosquito to 
mammalian transition in Plasmodium, where mRNAs overexpressed in salivary gland 
sporozoites are kept in a translationally repressed form that are to be expressed upon 
host switch, is also observed in female gametocytes during host switch.  An RNA 
helicase, DOZI (development of zygote inhibited) was found to be important for this 
process in P. berghei (113, 114).  DOZI knockout female gametocytes produced 
normal female gametes and zygotes; however, zygote to ookinete differentiation was 
halted before meiosis (114).  DOZI is localized with CITH and 14 other core 
components to a cytoplasmic assemblies called P granules (113).  These granules 
protect overexpressed but untranslated mRNAs in female gametocytes.  In DOZI 
knockout female mutants, those mRNAs are degraded (113, 114).  DOZI knockout 
male mutants produce ookinetes normally, suggesting this translational repression is a 
female-specific program (114).  A wide variety of mRNAs including known 
transcription factors required for maturation of ookinetes as well was ookinete cell 
surface markers required for diverse ookinete functions are protected by these P 
granules (113).  A matched transcriptomics and proteomics analysis of female 
gametocytes corroborates the existence of this phenomenon, where a large number of 
protein products from overexpressed mRNA are undetectable in female gametocytes 
(94).  Gene ontology enrichment analysis on putatively transcriptionally repressed 
genes in female gametocytes identifies meiosis as the highest enriched biological 
process, which is consistent with ookinete developmental arrest before meiosis in 
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female DOZI knockout mutants (94, 114).   
The energy metabolism of male and female gametocytes is also divergent.  
Chemical inhibition or genetic disruption of the TCA cycle and oxidative 
phosphorylation is very deleterious for Plasmodium in mosquito stages but well-
tolerated in the asexual blood stage, as glycolysis is the overwhelmingly major source 
of energy in RBC stage Plasmodium (115, 116).  The gametocytes, however, show an 
intermediate phenotype.  Gender independent analysis of the proteome of gametocytes 
suggests the presence of the TCA cycle and ETS components in them (117).  Male 
gametocyte activation, usually measured through the exflagellation rate of male 
gametocytes, is affected by chemical inhibition of glycolysis while female gamete 
activation remains unaffected (116, 118).  If components of oxidative phosphorylation 
are knocked out, the female gametocyte development and zygote to ookinete 
transformation are disrupted, but male exflagellation is unhampered (119, 120).  Taken 
together, it suggests that male gametocytes depend on glycolysis-based energy 
production, just like asexual Plasmodium, but the female gametocytes are not 
completely dependent on glycolysis and start to shift towards mitochondrial energy 
production as used by the ookinete stage.   
Importantly, male and female gametocyte maturation and release are 
synchronized in space and time, so that both male and female gametes can come out 
together in the mosquito midgut and find each other.  Therefore, even though the 
gametes develop differently, they most likely respond to the same or similar 
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extracellular stimuli, using similar intracellular components.  For example, calcium and 
cGMP signaling plays critical roles in the egress of both gametes (107, 121).  Chemical 
inhibition, as well as genetic disruption of cGMP-dependent protein kinase PKG and 
cGMP phosphodiesterase, causes inhibition of both male and female gamete activation 
(121-123).  Conditional disruption of calcium-dependent protein kinase CDPK1 leads 
to delayed microgamete emergence from male gametocytes, as well as a severe arrest in 
ookinete development (124, 125).  Molecular characterization of the later phenotype 
showed that CDPK1 activity acts as a switch to turn off the transcriptional silencing 
program in female gametocytes (125).  
 
 
1.4.5:  Zygote to Ookinete, Ookinete to Oocyst, and Oocyst to Sporozoite 
differentiation 
Global transcriptomic and proteomic comparison between zygote and ookinete 
is inherently difficult, as gametocyte to ookinete transformation occurs very rapidly.  A 
few studies where this aspect of differentiation was analyzed reported the presence of 
several enriched mRNAs and proteins in ookinetes stages with potential function in 
invasion and metabolism (111, 112).  Several gene knockouts in Plasmodium resulted 
in ookinete maturation defects, but a substantive number of them are also transcribed 
specifically in female gametocytes, suggesting they are likely to be regulated via the P 
body mediated translational repression program (107, 126, 127).  For example, the most 
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commonly used ookinete markers, P25 and P28, are important for ookinete maturation 
and function (128).  Their transcription occurs in female gametocytes, but they are 
translated only after the transcriptional repression program is turned off (114).    
The differentiation of ookinete to oocyst is scarcely studied in Plasmodium, and 
recent data suggest that large scale transcriptional differences exist between these two 
stages (129).  Targeted disruption of several AP2 transcription factors resulted in 
dysfunctional ookinete or oocyst formation (62, 63).  However, temporal regulation of 
these mutants along the ookinete development trajectory has not been studied in fine 
detail.       
Targetted analyses of AP2 TFs in P. berghei and P. yoelii suggest that a 
continuous spectrum of progression from female to ookinete to oocyst is controlled by 
different AP2 TFs (62-64, 89).  For example, in Plasmodium berghei, AP2-FG is 
required for female gametocyte maturation, AP2-O1,2,3,4 are required for ookinete 
maturation and oocyst establishment, and AP2 SP1,2,3 are required for oocyst 
maturation to form sporozoites (62).  In P. yoelii, another putative TF, HMGB2, was 
found that regulates ookinete maturation (130).  An AP2 TF specifically required for 
male gametogenesis has not been described yet.   
 
1.5:  Toxoplasma gondii Stage Differentiation 
T. gondii gondii has extensively been used as a model apicomplexan parasite 
due to relative ease of in vitro culture, earlier development of genetic tools, and 
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availability of well-established animal models compared to other apicomplexans (131).  
It is reported to be capable of infecting any nucleated animal cell, and is routinely 
cultured in human foreskin fibroblast (HFF) cells in laboratory settings (132).  Warm-
blooded animals are intermediate hosts of the parasites, which become infected by 
ingestion of oocysts (found in the feces of cats, the definitive host) or tissue cysts 
residing in the tissues of an animal (Figure 2).  In the gut, tissue cysts release 
merozoites that infect intestinal epithelial cells where they asexually replicate by 
endodyogeny, a special form of replication characterized by forming two daughter cells 
within a mother cell and ultimately consuming it.  Asexual replication usually gives rise 
to eight tachyzoites that lyse the host cell and infect nearby cells.  If tachyzoites gain 
access to leukocytes, they migrate to different tissues.  In immunocompetent hosts, 
tachyzoites ultimately differentiate into bradyzoites, a slowly replicating quiescent form 
that is subsequently enclosed by a cyst wall within the host cell.  The number of 
bradyzoites in the tissue cysts range from two to hundreds.  This encystation process 
establishes a lifelong asymptomatic chronic infection of T. gondii.  In the case of 
immune suppression of the host, e.g. by infection or chemotherapy, tissue cysts can be 
reactivated and the bradyzoites differentiate back into tachyzoites.  Eating raw meat 






1.5.1: Tachyzoite-Bradyzoite differentiation   
1.5.1.1.: Lessons from the Induction Signals 
Stress has been established as the key environmental stimulus for tachyzoite to 
bradyzoite differentiation.  It can be applied in various forms like temperature or PH 
change, drug administration, activation of the host immune system, and metabolic 
inhibition (133).  Interrogation of how such diverse stresses induce the same phenotype 
of tachyzoite to bradyzoite differentiation led to the characterization of eIF2α 
(eukaryotic Initiation Factor 2 alpha) phosphorylation, a known marker of the 
eukaryotic stress response, in T. gondii (134).  eIF2α is a highly conserved transcription 
initiation factor in eukaryotes that is repressed by phosphorylation (135).  Several 
above-mentioned stressor classes induce phosphorylation of eIF2α in T. gondii, and this 
phosphorylation mark is kept in bradyzoites, suggesting a link to this phosphorylation 
to bradyzoite differentiation (136).  Chemical inhibition of phosphorylation led to 
reduced bradyzoite conversion, and also reduced tachyzoite lytic proliferation both in 
vivo and in vitro (137).  On the other hand, inhibition of eIF2α dephosphorylation 
increases the bradyzoite conversion rate and inhibits the reactivation of bradyzoites 
(138).  These data indicate that eIF2α phosphorylation is necessary for bradyzoite 
differentiation.  Four classes of eIF2α kinases have been identified in T. gondii that 
phosphorylate eIF2α in under distinct stress conditions (134, 136, 139-141).  Gene 
knockout of two of these kinases inhibits eIF2α phosphorylation and the mutant 
tachyzoites showed reduce infectivity in in-vitro cell culture after specific stress 
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inductions (139, 140).  Replacing the wild type eIF2α with a phosphorylation deficient 
eIF2α phenocopies both of the kinase knockouts (139, 140, 142).  Additionally, death is 
delayed in mice infected with these mutants (139, 140, 142).  Therefore, eIF2α 
phosphorylation is also important for the lytic tachyzoite.  In several other systems, 
phosphomimetic versions of eIF2α have been described (143-146).  In T. gondii, such 
mutant eIF2α expression has not been described yet.  It would be interesting to observe 
if phosphomimetic eIF2α expression is possible in T. gondii and if yes, would it be 
sufficient to drive tachyzoite to bradyzoite differentiation.    
Several stressors that induce bradyzoite differentiation hamper mitochondrial 
function.  Atovaquone, a drug that targets apicomplexan mitochondrial activity, was 
found to be ineffective against a clone of T. gondii that spontaneously differentiates 
into bradyzoites (147).  It led to the testing and validation of atovaquone and some 
other drugs that supposedly act on mitochondria to be inducers of bradyzoite 
differentiation (147).  IFNγ, another inducer of bradyzoite differentiation, induces 
macrophages to produce nitric oxide, which in turn reacts with Fe-S clusters of the 
mitochondrial respiratory chain, rendering the organelle dysfunctional (148).  When 
bradyzoite and tachyzoite extracts were tested for the enzymatic activity of several 
glycolytic and TCA cycle enzymes, bradyzoite extracts showed higher activity for 
glycolytic enzymes (149).  Recently, it has been shown that knocking out hexokinase, 
the first enzyme in the glycolytic breakdown of glucose, severely blocks bradyzoite 
formation in mouse brain, but only modestly affects lytic replication of tachyzoites 
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(150).  Isotope-labeled metabolite tracking showed that tachyzoites can use glutamine 
in the TCA cycle to generate energy in the absence of glucose utilization, and also 
synthesize glycolytic intermediates from gluconeogenic pathways (150).  Taken 
together, all these observations suggest that mitochondrial respiration is important for 
tachyzoite energy production, but not so critical for bradyzoite energy production.  
One bradyzoite inducing compound, called compound 1, greatly exemplifies the 
role of the host cell on bradyzoite differentiation (151).  This compound was initially 
identified as an inhibitor of cGMP-dependent PKG (152, 153).  Interestingly, 
pretreatment of HEF cells with compound 1 resulted in the induction of bradyzoite 
differentiation (151).  Microarray analysis of host cells revealed that the expression of 
cell division autoantigen-1 (CDA1) is 47-fold upregulated in response to compound 1 
treatment.  RNAi-mediated silencing of CDA1 rendered parasites insensitive to 
compound 1, whereas overexpression of CDA1 induced differentiation similar to the 
level of compound treatment (151).  CDA1 can inhibit cellular growth, and also is 
implicated in tumorigenic and DNA damage response pathways in mammalian cells 
(154).  Indeed, cell types that do not grow rapidly, like terminally differentiated 
neurons or muscle cells, are more permissive to bradyzoite cyst formation (155, 156).  
The molecular mechanism of how the host cell’s replicative potential is transmitted to 
the parasite is still unknown.  Different cell types respond differently in terms of their 
global gene expression pattern and common pathways have not been identified that can 
robustly explain the host cell-type tropism of bradyzoite differentiation (155, 157).   
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1.5.1.2:   Lessons from the -Omics Studies 
Tachyzoites and bradyzoites differ extensively in the global gene expression 
pattern.  Early realization of this fact came from stage-specific antigen detections in 
these two forms.  It led to stage-specific cDNA library constructions and the 
identification of stage-specific genes (158-161).  The highly used tachyzoite specific 
marker SAG1 and bradyzoite specific marker BAG1 were identified in such a manner 
(159, 161).  Subsequently, the development of techniques like suppression subtraction 
hybridization (SSH) (162), microarray (163-171), comparative RNA-seq (172-176), 
and mass spectrometry-based comparative proteomics (177) have allowed comparison 
of the global gene expression patterns in tachyzoites and bradyzoites in high temporal 
resolution along the pathway of differentiation.   Several major insights are gained from 
these “-omics” data that are also validated by other more targeted experiments.  For 
example:  
1) The transcriptome and proteome of bradyzoites remain dynamic for a long 
time even after the formation of bradyzoites in the mouse brain, and only become more 
static three months post-infection (173).  This goes well with the observation that 
bradyzoites within tissue cysts are not completely dormant; instead, they continue to 
replicate and run other metabolic functions at a very low rate (169, 178, 179).   
2) Several metabolic enzymes and some other proteins have isoforms in T. 
gondii, and they are differentially expressed in tachyzoites and bradyzoites.  This was a 
well-known phenomenon that was discovered even before the use of -omics studies on 
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T. gondii (180, 181).   
3) The cell cycle progression of tachyzoites shows two distinct stages of 
transcriptome, G1 phase and S/M phase (182).  The transcriptome of a bradyzoite 
formation deficient mutant under stress condition has more similarity to S/M phase 
(169, 171).  This supports the notion that during bradyzoite differentiation, a G2-like 
phase of the cell cycle is activated that is normally present in the eukaryotic cell cycle 
in between S and M phase but is not observed in the T. gondii cell cycle (183).    
4) The tachyzoite transcriptome is differentially enriched for proteins in the 
TCA cycle and oxidative phosphorylation (174).  This supports the currently held view 
that bradyzoites are more dependent on anaerobic glycolysis for energy production 
(149, 150).  
 
 
1.5.1.3:  Role of Epigenetic Regulators and Transcription Factors 
The high number of differentially expressed genes between tachyzoite and 
bradyzoite suggests the presence of a global regulator of gene expression in this 
differentiation process.  Epigenetic changes and transcription factors are obvious 
suspects that can bring such a high variation of global gene expression.  A common 
epigenetic DNA modification in eukaryotes is cytosine methylation, catalyzed by DNA 
methyltransferases.  DNA is more methylated in the bradyzoite stage compared to the 
tachyzoite stage.  There are two DNA methyltransferases in T. gondii, both of which 
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are upregulated in the bradyzoite stage (184).  On the other hand chemical inhibition or 
genetic knockout of epigenetic histone modifiers also affected the bradyzoite 
differentiation rate (171, 184-186).   
The well-established role of AP2 TFs in Plasmodium differentiation motivated 
researchers to look for the role of their T. gondii homologs in bradyzoite differentiation.  
Knockout or overexpression of several AP2 TFs in T. gondii positively or negatively 
affected bradyzoite differentiation and cyst formation.  However, none of these mutants 
could completely turn on or turn off the differentiation despite affecting the expression 
of several stage-specific genes (187-191).  For example, AP2IX-9 expression peaks at 
two days post bradyzoite induction and declines thereafter, whereas AP2IV-3 
expression rapidly increases also at day two and slowly keeps increasing or is 
maintained thereafter (189).  AP2IX-9 is a putative transcriptional repressor that is 
shown to repress the expression of bradyzoite marker BAG1 (191).  On the other hand, 
AP2IV-3 is a putative transcriptional activator that is demonstrated to activate BAG1 
expression (189).  In accordance with their role in BAG1 transcriptional regulation, 
AP2IX-9 and AP2IV-3 knockout mutants enhanced and reduced bradyzoite 
differentiation respectively (189).  The overlap in the expression pattern of these two 
transcription factors exemplifies the highly dynamic nature of the early stages of 
bradyzoite differentiation.  Indeed, parasites within a single vacuole or even a single 
parasite express markers of tachyzoites and bradyzoites together, during both 
bradyzoite-to-tachyzoite and tachyzoite-to-bradyzoite differentiation (192, 193).     
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The development of the CRISPR-Cas9 mediated forward genetic approach has 
been developed recently in T. gondii (194).  With this approach, the bradyzoite 
formation phenotype was analyzed in ~200 knockout mutants (176).  The tested gene 
set contained stage-specific genes, as well as known and putative transcription factors.  
Knockout of a single TF, BFD1, showed a bradyzoite formation deficiency phenotype.  
Furthermore, targeted disruption of BFD1 followed by single-cell RNA-seq based 
phenotypic characterization demonstrated that BFD1 is both necessary and sufficient 
for bradyzoite differentiation (176).  This is the first identification of a master regulator 
of bradyzoite differentiation.  How this TF itself is regulated in response to different 
classes of stress is still to be determined.  
1.5.2:  T. gondii Sexual Differentiation 
Cats are the definitive host of T. gondii.  They can get infected by tachyzoites, 
bradyzoite containing tissue cysts, and sporozoite containing oocysts.  The preferred 
form for causing feline infections seems to be tissue cysts, as its prepatent period (time 
to shed oocyst in the feces) is 3 to 10 days, followed by tachyzoites (prepatent period 
>13 days), and oocysts (>18 days) (28).  Life cycle progression in cat intestinal 
epithelial cells, determined by electron micrograph and described in only a few 
publications, is as follows: 
The sporozoites from oocysts start infection, and replicate asexually via the 
tachyzoite replication cycle.  Tachyzoites differentiate into bradyzoites, most likely due 
to immune system derived stress.  The bradyzoites differentiate into five 
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morphologically distinct forms in a stepwise manner, potentially asexually replicating 
multiple times within each form.  Finally, from a schizont-like form, merozoites appear 
that differentiate into male and female gamonts in the cat intestinal epithelium.  Male 
gametes fertilize female gamonts to form zygotes, which are then differentiated into 
oocysts.  Rupture of infected epithelial cells releases oocysts into the lumen that are 
ultimately excreted in the feces.  Mitosis and meiosis produce two sporocysts, each 
containing four sporozoites (Figure 2).  For a more detailed description of this life cycle 
with a description of each form, see reference (28).  Until very recently, the bradyzoite 
to oocyst differentiation could only be observed in feline intestinal epithelial cells in 
vivo, which is a difficult experimental system to get access to (195).  Therefore, 
molecular characterization of the intermediate stages is very limited (196, 197).  
Despite the fact that cats are not a readily accessible experimental system, 
several comparative transcriptomics studies have been performed along this line of 
differentiation.  Transcriptomes from three stages of oocyst maturation and merozoites 
were compared with in vitro tachyzoites and bradyzoites using microarray (198, 199).  
More recently, RNA-seq has been used to compare the transcriptome of merozoites, 
five separate timepoint samples along the sexual differentiation path from T. gondii 
infected cat intestinal epithelial cells, and tachyzoites (31, 200).  Combining data from 
these experiments, stage-specific expression profile was determined for each of the 
stages and was used heavily to characterize a mutant parasite whose MORC gene can 
be conditionally knocked out (201).  MORC is an ATPase protein that provides energy 
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for epigenetic modification of histone by histone deacetylase 3 (HDAC3) (201).  
Conditional knockdown of MORC, as well as chemical inhibition of HDAC3, silenced 
a large set of target genes (validated by Chip-seq), which are mostly enriched in 
gamonts and somewhat enriched in oocysts and bradyzoites (184, 201).  It led to the 
conclusion that epigenetic histone modification by the HDAC-MORC complex 
suppresses parasite differentiation towards sexual replication.  These are the only 
characterized global regulators of the T. gondii sexual differentiation pathway so far 
(201).  
A long-standing question in the field of T. gondii was why the sexual cycle only 
takes place in the feline intestine.  Recently, it was shown that the cat is the only 
mammal that lacks a specific fatty acid breakdown enzyme, which allows the buildup 
of linoleic acid in cats that triggers the sexual differentiation (202).  Both linoleic acid 
supplementation in in vitro culture and inhibiting the degradation of linoleic acid in 
mice allowed the sexual cycle to commence both in vitro and in vivo in a mouse model 
(202).  Even though the molecular detail of this signaling is still unknown, this 
discovery has made the experimental system of T. gondii sexual differentiation hugely 
accessible compared to the previous state (203).  It could potentially lead to a better 






1.6:  Cryptosporidium Stage Differentiation 
Cryptosporidium species are parasites of the vertebrate gastrointestinal tract 
(204).  They can complete their life cycle within a single host.  Many of the reported 
species can infect multiple hosts, both naturally and experimentally.  For example, C.  
hominis is the major human pathogen of the genus and can also infect gnotobiotic 
piglets experimentally.  C.  parvum can infect both humans and cows naturally, and 
immunocompromised mouse models experimentally (205).  Once considered as a 
coccidian, phylogenetic analysis now shows that this single genus constitutes a separate 
clade of Apicomplexa, which is phylogenetically more similar to gregarines than 
coccidians (206).   
Oocysts are the infectious forms of the parasite that disseminate through the 
fecal oral route (Figure 3).  Four sporozoites come out from an oocyst and infect 
intestinal epithelial cells (IECs).  They form a parasitophorous vacuole (PV) within the 
host cell that is localized just under the plasma membrane, a peculiar localization that 
has often been described as intracellular but extracytoplasmic (207).  Within the 
vacuole, Cryptosporidium transforms into trophozoites that develop into type I meronts 
containing six to eight type I merozoites, which come out and infect nearby IECs 
within a day post infection.  After several rounds of this asexual replication, they 
differentiate into type II meronts containing type II merozoites, which in turn develop 
into gametocytes after infecting the IECs.  Microgametocytes produce around 16 male 
gametes that come out and fertilize uninucleate female gametocytes residing in a host 
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cell.  Gametocytes start to emerge 42 hours post C. parvum infection in vitro and they 
are the terminal form of Cryptosporidium differentiation in the human colorectal 
carcinoma cell line HCT-8, which is commonly used for in vitro cultivation.  In vivo, 
fertilized zygotes differentiate into oocysts and, during their development, meiotic cell 
division within the PV forms four sporozoites.  Two types of oocysts have been 
described for Cryptosporidium, thin-walled oocysts that autoinfect the host and thick-
walled oocyst that are excreted into the environment (204, 208, 209).   
Cryptosporidium infection is asynchronous, which makes it difficult to 
determine the number of asexual cycles before commitment to gametogenesis (204, 
208, 209).  The different stages are mainly described via electron microscopic 
observations (208, 210).  Until very recently, there were no clear markers to 
differentiate different stages of the Cryptosporidium life cycle using light microscopy.  
The dogmatic view in the field is that sexual differentiation is an obligate step 
following several rounds of asexual replication.  However, it is hard to determine if 
asexual cycles continue in parallel to sexual differentiation within the vertebrate host, 
because even if they are observed together, the asexual forms might result from 
subsequent rounds of infection from the autoinfective thin walled oocysts.  Commonly 
used cell culture methods cannot support the life cycle completion in vitro, and cultures 
collapse after the majority of the parasites progress into gametocytes (211).  Without 
molecular characterization, it is also difficult to determine if in vitro progression to 
gametocytes is predetermined or an induced event caused by in vitro culture conditions.  
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Recently, using a cleverly designed transgene cassette for Cryptosporidium that 
only supports fluorescent protein expression upon fertilization, it was shown that 
fertilization is blocked in the HCT8 cell culture system (212).  One of the possible 
explanations for this observation can be that the gametocytes do not fully mature in the 
culture.  Transcriptome comparison of Cryptosporidium at 48 hours and 96 hours post 
infection using RNA-seq reported that around 500 genes are differentially expressed 
between in vivo and in vitro conditions (213).  However, the asynchronous nature of 
the parasite infection inhibited assigning differentially regulated genes to specific 
stages of the life cycle.   59 of the upregulated proteins in vivo are secreted proteins that 
include one of the major oocyst wall proteins and several other uncharacterized large 
glycoproteins that are potential oocyst wall components.  In comparison, only six 
upregulated proteins in vitro are secreted proteins.  While the proteins upregulated in 
vivo might be required for female gamete formation, they also might be expressed 
following fertilization.  Therefore, macrogamete formation deficiency could not be 
completely verified in this study (213).  A cleaner comparison of macrogamete 
development was performed by expressing a fluorescent protein under a female specific 
promoter and FAC sorting macrogametes from in vivo and in vitro conditions for RNA 
seq (212).  This comparison did not suggest any major dysregulation of female 
gametocyte specific gene sets except that in terms of global gene expression in vivo 
females had comparatively more similarity to sporozoites compared to in vitro females 
(212).  This observation can be explained by the fact that FAC sorting of the in vivo 
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population also isolated zygotes and immature oocysts, as they also fluoresce in this 
system (212).  Potential microgamete development deficiency in vitro has not been 
tested robustly yet.   
One of the recently developed stem cell-derived platforms that supports oocyst 
production in vitro utilizes differentiation of mouse intestinal stem cells at air-liquid 
interface (ALI) as a culture platform (214).   The host cell differentiation is blocked in 
the absence of ALI condition, and consequently, Cryptosporidium growth is also 
significantly affected.  This system is well suited to test the effect of host cell gene 
expression on Cryptosporidium differentiation.  Comparison of ALI and non-ALI 
culture host cell transcriptomes suggest that several pathways are significantly 
differentially regulated between those two conditions.  Specifically, the energy 
metabolism of the ALI culture significantly shifts from glycolytic to mitochondrial 
respiration (214).  Taken together with the above-mentioned studies about 
macrogamete development, this suggests that the discontinuation of Cryptosporidium 
growth in different cancer cell lines may actually result from the differences in host cell 
characteristics rather than gametocyte development deficiency.  However, the exact 
molecular mechanism of this phenomenon is still to be elucidated.  
The transcriptome of sporozoites at varying in vitro culture time points has 
revealed that Cryptosporidium has a highly dynamic transcriptional regulation as it 
progresses through its life cycle, and there are numerous stage specific genes (213, 215, 
216).  A high throughput qRT-PCR based analysis has the highest temporal resolution 
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of transcripts so far (215).  This study captured seven different time points ranging 
from 2 hours to 72 hpi in vitro.  In combination, two RNA-seq studies also assayed the 
transcriptome of 2, 24, 48 and 96 hpi, as well as oocysts and sporozoites (212, 216).  
Despite differences in host cell lines, sampling times, methods used, and analyses 
modules, these three sets of data are fairly consistent and provide similar conclusions 
regarding several broad aspects of life cycle progression.  For example, the gene 
expression pattern in intracellular stages is more diverse compared to sporozoites and 
oocysts, with a huge shift towards rapid transcriptional activities observed at early 
intracellular timepoints.  Later time points in all the experiments showed enrichment of 
oocyst wall proteins and meiosis associated proteins.  Importantly, the later time points 
contain a mixture of both male and female gametocytes in these experiments (213, 215, 
216).  RNA-seq mediated comparison between FAC sorted female parasites and 
asexual stages verified that both of the above-mentioned protein classes are enriched in 
female gametocytes (212).  One interesting observation from both of the bulk RNA-seq 
experiments was that mRNA of one paralogue of two lactate dehydrogenase genes of 
Cryptosporidium is selectively highly expressed in the sporozoite population (213, 
216).  In a microarray experiment of oocysts, the same observation was reported (217).  
The potential functional significance of this observation is still to be realized.  
The high temporal resolution of the qRT PCR dataset noted above makes it 
suitable for the exploration of co-expressed gene clusters.  Indeed, in the original 
publication, they divided the genes into nine clusters based on their temporal 
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expression profiles (215).  Subsequently, another study used the same dataset and, 
using an optimized parameter for clustering it described 200 different clusters of co-
expressed genes (218).  Several short DNA motifs were enriched in the promoter 
elements of several clusters (218).  An in vitro AP2 TF DNA binding assay showed that 
some of the identified motifs are recognized by multiple Cryptosporidium AP2 TFs 
(219).  For example, the motif “GCATGCA” was found to be overrepresented in 33 of 
200 clusters (218).  The DNA binding assay showed that slight variations of this motif 
are identified by four different AP2 TFs.  Taken together, it suggests that AP2 TFs play 
important roles in stage-specific transcription of Cryptosporidium genes.  
Several recent breakthroughs have made studying the differentiation of 
Cryptosporidium life cycle progression more amenable.  The parasite is now 
genetically manipulatable using CRISPR-Cas9 technology (220), distinct phases of its 
life cycle can be identified by stage specific antibodies (221), completion of its life 
cycle is possible in vitro (214, 222-226) and stage specific assays are available (209).  
Together, these developments constitute a strong toolbox to progress our understanding 
of the Cryptosporidium life cycle beyond microscopic observation to molecular 







1.7:  Eimeria Stage Differentiation 
Eimeria species are coccidian apicomplexans that can infect all classes of 
vertebrates and some invertebrates (227).  Each species is considered to be specific for 
a single host, within which they complete their whole life cycle (227).  Several Eimeria 
species are parasites of chickens that cause huge economic losses in the poultry 
industry.  The most well studied species of them is Eimeria tennela.  
Eimeria oocysts form sporocysts within them in the environment (Figure 4).  
Upon ingestion, they are released in the chicken gastrointestinal tract.  Sporozoites 
come out of the sporocyst in the small intestine and infect the intestinal epithelial cells.  
After several rounds of asexual schizogony, where multiple merozoites from a schizont 
start another round of replication, gametes emerge, fertilization takes place, and 
subsequently, the zygotes differentiate into oocysts that are excreted in the feces (228).  
Based on the observations of morphologically different schizonts that emerge in a time-
dependent manner after chicken infection, the dogmatic view is that Eimeria species 
are genetically programmed to replicate for a fixed number of asexual schizogony 
cycles before differentiating into gametocytes (228, 229).  For example, upon E. 
tennela infection, first generation schizonts are observed at day 1 and 2 post-infection, 
the second generation of schizonts, which are larger and contain more nuclei than the 
first generation, are observed on day 3 and 4 post-infection, and third generation 
schizonts, which are smaller than both of the earlier schizont stages and contain up to 
16 merozoites, are observed after 4 days of infection (228, 230).  Merozoites from the 
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third stage schizont develop into gametocytes that start to emerge at day 5, which 
ultimately form the zygote.  Oocysts are abundant in the feces on day 6 to 7 post 
infection (228, 230).   
Several controlled experiments support the theory of preexisting genetic 
programs for the number of asexual replication cycles.  For example, in a study testing 
this theory, merozoites were collected from chicken intestine 94 hpi (hours post-
infection) and used to infect naïve chickens by direct intestinal injection (231).  This 
inoculum is supposedly enriched for the second generation of merozoites and, in 
agreement with the theory, none of the earlier stage schizonts were observed in the 
naïve chicken.  Third stage schizonts, gametocytes, and oocysts emerged at earlier time 
points compared to chickens infected with oocysts (231).  Recently, RNA-seq and SSH 
techniques were used to determine the gene expression pattern of E. necatrix 
merozoites collected at 136 and 144 hpi.  The two populations were considered the 
second and the third generation of merozoites respectively.  A high number of genes 
were found to be differentially expressed and they were classified into second or third 
generation-specific genes (232, 233).   
However, in vivo infection of Eimeria is asynchronous which makes it difficult 
to differentiate different stages of schizont based on size only (228, 229).  
Consequently, merozoite isolation at a certain time point post-infection would likely 
result in a diverse set of merozoites from different replication cycles.  Additionally, 
instead of a replication number clock, there might be environmental signals that drive 
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the differentiation and as such, the parasites at different timepoints post infection might 
be at different stages of development/differentiation, irrespective of the number of 
schizogony cycles that they went through.  Therefore, in the absence of specifically 
defined markers for each schizogony cycle and/or without genetic validations about the 
existence of distinct schizogony stages, the theory of a genetically determined 
replication number cannot be properly tested.   
Attempts of attenuated vaccine development present another approach to test 
this phenomenon.  It has been shown that repeated isolation of early oocysts and their 
selection by serial passage gives rise to less virulent precocious lines of Eimeria whose 
prepatent time decrease significantly from the parent parasites (234-237).  Most 
commonly, fewer asexual replication cycles have been attributed to such shortened 
prepatent time of precocious lines (234, 237, 238).  Searching for a potential genetic 
basis of the fewer asexual cycles that occur, one study crossed a precocious line with its 
parent and identified a genetic linkage in chromosome 2 associated with the shorter 
prepatent time phenotype (239).  Recently, another study looked for differences in 
transcriptional activity of a precocious and its parent line and suggested potential 
differences exist in the expression of DNA replication related genes at merozoite stages 
(234).  Heritable epigenetic changes can also cause such a phenomenon; however, 
epigenetic comparison between a parent and a precocious line has not been described 
yet.   
To probe the commitment towards sexual differentiation in Eimeria, a study 
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used periodic acid-Schiff (PAS) staining in primary chicken kidney cell culture and 
reported that PAS-positive third generation schizonts form PAS-positive third 
generation merozoites that ultimately form PAS-positive macrogametocytes (240).  The 
opposite was observed for microgametocyte development.  This suggests that parasites 
are committed to forming either male or female gametocytes one replication cycle 
before the ultimate differentiation, similar to the Plasmodium parasites.  However, this 
phenomenon has not been tested robustly with modern techniques.  
Several studies have used comparative transcriptomics and proteomics analysis 
to understand the regulation of the life cycle progression of Eimeria (200, 232-234, 
241-243).  Analysis of the proteome of oocysts, in vitro sporulated sporozoites, and 
merozoites isolated from infected chickens suggested that merozoites express proteins 
involved in oxidative phosphorylation more abundantly, whereas glycolytic enzymes 
are expressed almost equally between sporozoites and merozoites (242).  Another study 
used RNA-seq to determine differential expression of genes between sporozoites, 
asexual merozoites (collected 112 hpi) and gametocytes (gender independent, 134 and 
144 hpi) (200).  Genes that were upregulated in gametocytes contained enzymes for 
protein glycosylation and proteases, both of which classes were previously described as 
upregulated in gametocytes in independent studies (244, 245).  Comparison of this 
dataset with Plasmodium sex-specific transcriptomic datasets showed that homologs of 
both male and female specific Plasmodium genes were upregulated in gametocytes in 
this dataset (200).  Antisera raised against some of these proteins successfully 
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differentially identified male and female gametocytes (200), which could be very 
helpful for future differentiation studies.  
Recently, a breakthrough publication in E. tenella described new gene knockout 
techniques in Eimeria using CRISPR-Cas9 mediated genetic manipulation techniques 
(246).  The Cas9 protein was also successfully integrated into the genome, which 
creates a very amenable system for mutant library preparation (246).  This study also 
demonstrated a successful knockout of 10 of the 33 putative AP2 TFs in the E. tennela 
genome, suggesting the others were essential (246).  With this newly developed 
technique, long-standing questions in Eimeria life cycle progression can be addressed 
in a more comprehensive way.  One still standing roadblock in the field is the absence 
of an easily manipulatable continuous culture system.        
 
1.8:  Stage Differentiation of Piroplasms 
Piroplasms are a group of hematozoan apicomplexan parasites that infect blood 
cells of vertebrates for asexual replication and blood-sucking ticks for sexual 
replication (247).  Phylogenetically, they are the closest relatives of Plasmodium 
among the parasites discussed in this review.  Babesia and Theileria infect cattle while 
Babesia can also infect humans as a dead-end host (Figure 5).  Hard ticks of the family 
Ixodidae are their definitive host who takes up the mature gametocytes of these 
parasites residing in RBCs of mammalian hosts (248).  In the tick midgut, 
gametogenesis and fertilization takes place, zygotes are formed in the midgut cells, 
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followed by meiosis to produce kinetes.  Kinetes migrate to the salivary gland of the 
tick via hemolymph, and differentiate into sporoblasts that contain sporozoites, which 
are the vertebrate infective form.  Babesia sporozoites directly infect RBCs, while 
Theileria sporozoites first infect leukocytes.  Theileria merozoites released from 
leukocytes then infect RBCs.  The asexual replication cycle and occasional 
gametocytogenesis occur within RBCs, ultimately forming mature gametocytes.  Even 
though there are several steps in the piroplasm life cycle where differentiation occurs, 
our knowledge about molecular mechanisms governing these steps is extremely limited 
(248).  
1.8.1:  Theileria 
Most of the pathogenic Theileria species can cause an oncogenic transformation 
of the leukocytes that they infect (249).  They replicate via schizogony inside the 
parasitophorous vacuole within a transformed cell, and when the host cell is mitotically 
divided, they are distributed into daughter cells (250).  Importantly, this transformation 
is reversible.  Typically, Theileria are cultivated in vitro in transformed leukocytes 
(249).  Different aspects of this transformation process have been studied relatively 
more extensively than progression of the parasite beyond this stage of the life cycle 
(251).  They progress to the RBC stage by producing merozoites that egress from the 
leukocytes.  The observation that the number of nuclei in the schizont increases before 
merozoite formation led to the theory that a high ratio of DNA compared to protein in 
the parasitophorous vacuole signals merozoite differentiation (252).  Inhibition of DNA 
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synthesis using a cell cycle progression inhibitor induced early differentiation, whereas 
a mitochondrial protein synthesis inhibitor prolonged the time before differentiation 
(253).  This led to a more refined theory that when specific protein factors in the 
parasitophorous vacuole reach a threshold, it induces commitment and the higher ratio 
of DNA in the earlier theory on commitment is just a facilitator for higher 
transcriptional activity (i.e. higher number of genomic copy allows higher transcription 
of a specific factor) in the multiple nuclei containing parasitophorous vacuole (253).  It 
was subsequently shown that a protein overexpressed during differentiation is 
transcriptionally regulated by putative transcription factors that are also enriched during 
differentiation (254).  This supported the notion that reaching the threshold of specific 
factors drives differentiation (254).  Increasing culture temperature is the most common 
way of inducing merozoite differentiation in Theileria (252-255).  It was shown that the 
protein synthesis rate of the parasite increases at the higher temperature (253).  Finally, 
stage-specific overexpression of 3 genes was verified by northern blotting (255).  
All these pre-omics era studies suggest that there is a stage specific expression 
of genes that drives differentiation.  Indeed, transcriptomic and proteomics studies 
confirm that there are stage specific expression profiles of genes in different stages of 
the Theileria life cycle, just like all the other Apicomplexa (256-258).  However, even 
though there are markers of different stages, wet lab experimental identification of a 
master regulatory element is still missing.  In silico analyses have shown that Theileria 
contains several AP2 TFs, and expression profiles of several of those AP2 TFs are also 
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stage specific (259, 260).  The genetic knockout system is still not developed for 
Theileria, however, so potential experimental validation approaches are limited at this 
point (261).  
1.8.2:  Babesia 
Several species of Babesia can be continuously cultured in-vitro within RBCs 
during their asexual replication cycle (262).  No schizogonic replication has been 
documented for Babesia yet (248).  In the mammalian blood, some parasites 
differentiate into gametocytes, which are activated in the tick midgut to form gametes 
(248).  Induction of gametocytogenesis, as well as gametogenesis, can be achieved in in 
vitro blood culture of Babesia (263-265).  Stressing the parasites with anti-Babesia 
drugs induces gametocytogenesis, whereas induction with xanthurenic acid or tick 
extract induces both gametocytogenesis and gametogenesis (265, 266).  There are three 
validated marker genes of gametocytogenesis, two of them are expressed in kenetes 
also (267, 268).  
Hap2 is a well documented male gamete specific protein in different systems, 
and it is functionally important for gamete fertilization (269).  Reducing Hap2 activity, 
either by functional inhibition using antibodies or by genetic knockout, inhibits zygote 
formation, suggesting a similar role for Hap2 in Babesia as seen in the other systems 
(270, 271).  A putative methyltransferase is only expressed in tick stages (268).  In 
addition to these markers, there are other potential stage specific proteins in Babesia 
that are identified through proteomics based analysis (272-274).   
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Global regulators of differentiation have yet to be identified for Babesia, and 
none of the AP2 TFs have been studied for differentiation in a targeted way yet (260).  
As a gene knockout system in Babesia is available (271, 275), knockout mutant derived 
validation of a master regulator is possible, and the already established stage specific 
markers would greatly help in that process.     
 
1.9:  Similarities and Differences in Stage Differentiation Between Apicomplexan 
Parasites  
During almost the entirety of their life cycle, all the discussed apicomplexan 
parasites have a haploid nucleus.  Zygotes are the only diploid stage, and in most cases, 
they are very short-lived because of the subsequent meiotic division.  Whether there are 
common underlying mechanisms of initiation of meiosis in response to the diploid state 
of the nucleus is not known.  
Sexual differentiation of the Apicomplexa starts with gametocytogenesis, which 
gives rise to male and female gametocytes.  The two gametocytes develop with highly 
divergent gene expression patterns, but they normally emerge together during the 
course of infection.  This suggests a two-step process of gametocytogenesis induction.  
First, a gender independent commitment step, and subsequently, a gender-specific 
differentiation pathway.  This has been well characterized in Plasmodium where Δap2-
g mutants do not form any gametocytes whereas Δap2-fg are only deficient in female 
gametocyte maturation.  A sexually committed schizont stage is observed in 
  
50 
Plasmodium within which the two above mentioned steps likely take place.  Hints of 
the same phenomenon have been also observed in Eimeria, where the schizonts in the 
last cycle are morphologically distinct from the earlier cycles, and in Cryptosporidium, 
where a type II meront is observed before the emergence of gametocytes.  Whether 
these two stages are analogous to the sexually committed schizont of Plasmodium has 
not yet been tested with molecular techniques.  
The time interval between commitment to gametocyte formation and the 
ultimate release of gametocytes differs between different apicomplexan species.  For 
hematozoans, mature gametocytes of both sexes need to come out from the host cell at 
the same time in the vector midgut.  In the case of Coccidians and Cryptosporidium, 
only the male gametes egress from the host cells, after which they fertilize mature 
female gametocytes residing in other host cells.  In any case, gametocyte maturation of 
both sexes must be synched in time for successful fertilization.   
Gametocyte development pathways seem to be well conserved within 
apicomplexans, as multiple transcriptomics and proteomics studies have shown that 
homologous proteins are expressed in a sex-specific manner for all the apicomplexans.  
For example, meiosis-related genes are expressed during the maturation of female 
gametocytes in different parasites, presumably so that the proteins for meiotic division 
are readily available soon after the fertilization.  On the other hand, expression of 
HAP2, a well-characterized gamete fusion protein, is restricted to male gametocytes in 
different apicomplexans.      
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Commitment to the next step of differentiation occurs before the ultimate stage 
conversion in almost all of the differentiation processes.  The only exception seems to 
be the tachyzoite to bradyzoite differentiation, which is more dynamic.  However, this 
particular differentiation is also unique in the sense that it is reversible.  Even including 
bradyzoite differentiation, identified global regulators of differentiation in different 
apicomplexans are highly common between species.  The family of AP2 TFs plays key 
roles in all the differentiation processes.  Post-translational regulation is also commonly 
observed in many differentiation processes.  For example, inhibition of translation 
initiation by phosphorylation of eIF2α is observed for Plasmodium sporozoite to liver 
stage conversion, and in tachyzoite to bradyzoite conversion.  However, this 
conservation can be artificially biased, as the selection of global regulators for in-depth 
studies is often guided by what is already known in other apicomplexans.  Indeed, when 
a relatively unbiased mutant library screen was used to identify key regulators for 
bradyzoite differentiation, it identified a myb domain containing TF, which was never 
implicated in apicomplexan differentiation before (176).  
Stage specific alteration in energy metabolism is also a well conserved feature 
of apicomplexan differentiation.  Some stages are more dependent on anaerobic 
glycolysis for energy production, whereas other stages are more reliant on oxidative 
phosphorylation.  The role of epigenetic modification of chromatin structure in 
differentiation is starting to emerge in apicomplexans, and will likely be recognized to 
play a role in many apicomplexans after further study.  
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1.10:  Future perspectives 
Several technological advances in recent years have made studies of 
apicomplexan differentiation more accessible.  Two techniques have potential high 
values in understanding differentiation across multiple apicomplexan species—namely, 
single cell RNA-seq and CRISPR-Cas9 mediated mutant library preparation.   
It is often difficult to differentiate different stages of the apicomplexan life cycle 
due to their asynchronous growth and lack of robust stage-specific markers.  In 
addition, the lack of an easily manipulatable in vitro culture system hinders studies of 
different apicomplexans.  Theoretically, single cell transcriptomics can overcome all 
these challenges.  Great examples of this are the two single cell transcriptional atlases 
of Plasmodium and T. gondii (129, 172).  From both of these studies, it is apparent that 
single cell transcriptomes from parasites at different stages of their life cycle cluster 
with unguided algorithms in a stage specific manner.  Deductive reasoning can be 
applied to such datasets from our knowledge on well-studied apicomplexans to 
determine the identity of each cluster.  As transcriptomes are generated from single 
cells rather than a population, they are theoretically more suitable for identifying sets of 
co-expressed genes.  Additionally, it is almost the ultimate phenotypic characterization 
tool when the phenotype is the differentiation capability .  
The second technique, CRISPR-Cas9 mediated mutant library preparation, is 
relatively restricted to parasites with already established robust transfection and genetic 
manipulation systems.  It is already available for Plasmodium and T. gondii, and also 
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probably for Eimeria (58, 194, 246).  CRISPR-Cas9 mediated library generation allows 
preparation of an unbiased mutant library, as well as relatively straightforward 
determination of library composition in various conditions.  The utility of this 
technique has already been seen for Plasmodium liver stage metabolic map 
construction, as well as in the identification of a master regulator of T. gondii 
bradyzoite differentiation (58, 176).  
There are still a lot of unanswered questions in apicomplexan differentiation.  
With the techniques that are now available together with unprecedented access to a 
wealth of “-omics” data, a lot of those questions are ready to be answered.    
 
1.11:  Summary of our approach  
We have applied a systemic chemical genomics approach to understand the 
regulation of C. parvum differentiation.  Using a stage specific differentiation assay, we 
screened a library of more than 10,000 compounds and identified compounds that 
specifically inhibit the sexual differentiation or maturation of C. parvum. The 
transcriptomic responses of the parasites to these sexual stage specific inhibitors were 
then determined using mRNA-seq. To our knowledge, this is the first time a chemical 
genomic approach has been used to study the process of differentiation in 
apicomplexans. Our data greatly complement the already published transcriptomics 
data available on Cryptosporidium life cycle progression. By robustly comparing our 
dataset with already published datasets of Cryptosporidium differentiation and other 
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apicomplexans, as well as analyzing the already known mode of actions of several 
sexual stage specific inhibitors, we have put forward several hypotheses regarding 
potential master regulatory elements and metabolic alteration of Cryptosporidium in the 
course of sexual differentiation. Our data highlight the potential commonalities of 
Cryptosporidium and other apicomplexans in driving differentiation, as well as 
















Figure 1:  Plasmodium life cycle.   
See section 1.4 for detailed description.  The illustration is a public domain image by 
“CDC - DPDx/ Alexander J. da Silva, PhD; Melanie Moser” and downloaded from 





















Figure 2:  Toxoplasma gondii life cycle.   
See section 1.5 for detailed description. The illustration is a public domain image by 
“CDC - DPDx/ Alexander J. da Silva, PhD; Melanie Moser” and downloaded from 




















Figure 3:  Cryptosporidium life cycle.   
See section 1.6 for detailed description. The illustration is a public domain image by 
“CDC - DPDx/ Alexander J. da Silva, PhD; Melanie Moser” and downloaded from 

















Figure 4:  Eimeria life cycle. 
See section 1.7 for detailed description.  The illustration is licensed under “CNX 















Figure 5:  Babesia life cycle.   
See section 1.8 for detailed description. The illustration is a public domain image and is 
downloaded from cdc.gov. 
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CHAPTER 2:  A CHEMICAL GENETICS APPROACH TO UNDERSTAND 
THE REGULATION OF CRYPTOSPORIDIUM SEXUAL DIFFERENTIATION 
 
2.1:  Abstract 
Cryptosporidium is an intracellular protozoan parasite that is a leading cause of 
childhood diarrhea in Africa and Southeast Asia.  It is a member of eukaryotic phylum 
Apicomplexa, a group of intracellular parasites that replicate both sexually and 
asexually in the course of their life cycle.  Sexual differentiation of C. parvum is 
required for host to host transmission of the parasite as well as for autoinfection of the 
same host.  In this study, we have optimized and utilized an in vitro high content 
imaging assay to test compounds for activity against the sexual and asexual stages of 
the parasite separately.  The tested compounds comprise the ReFRAME library, a drug 
repurposing library composed of ~12,000 compounds for which extensive prior 
knowledge exists including their putative targets and modes of action.  Inhibitors of the 
host cell’s electron transport chain and purine nucleotide biosynthesis 
disproportionately affected the sexual differentiation of C. parvum.  To identify the 
stage specific genes and pathways as well as the potential key regulators of the sexual 
differentiation process, we used RNA-seq following treatments with nine 
differentiation inhibitor and found that a number of parasite genes were dysregulated 
with multiple compound treatments. Ribosomal protein genes were upregulated with 
differentiation inhibitor treatments, which suggests that global repression of protein 
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translation is associated with C. parvum sexual differentiation.  Analysis of publicly 
available RNA-seq datasets of C. parvum and other apicomplexan parasites indicates 
that this is a common mode of regulating apicomplexan stage differentiation.  Our data 
also implicate several apicomplexan AP2 transcription factors as key regulators of C. 
parvum sexual differentiation.    
 
2.2:  Introduction 
Cryptosporidium species are one of the most significant etiologic agents of 
childhood diarrhea in developing countries (1).  There is an urgent need to develop 
novel therapeutics, as current treatment options are inadequate for treating 
malnourished children and immunodeficient patients, the two populations most 
vulnerable to cryptosporidiosis (2).  The parasite is a member of the eukaryotic phylum 
Apicomplexa, which is comprised of intracellular protozoan parasites.  Malaria and 
toxoplasmosis are two other major human diseases caused by apicomplexan parasites. 
Cryptosporidium transmits through the fecal-oral route in the form of 
environmentally resistant oocysts.  In the mammalian gut, the oocysts excyst to release 
sporozoites that infect the intestinal epithelial cells (IECs).  Initially, it replicates 
asexually where intracellular trophozoites develop into type I meronts that release up to 
8 merozoites that can repeat this asexual cycle.  After several rounds of asexual 
replication, parasites differentiate into type II meronts (containing 4 merozoites instead 
of 8), and merozoites from type II meronts differentiate into gamonts upon infecting 
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IECs.  Gamonts are of two types:  uninucleated macrogamonts (i.e. female gamonts), 
and multinucleated microgamonts (i.e. male gamonts).  Male gamonts fertilize female 
gamonts by infecting a macrogamont-harboring IEC.  Meiotic cell division in the 
fertilized gamont produces 4 sporozoites that are subsequently enclosed by an oocyst 
wall and released from the host cell.  Oocysts either excyst within the same host to 
cause autoinfection or are released into the environment with feces (3).   
In the laboratory setting, oocysts can be excysted by treating with sodium 
taurocholate, and the sporozoites can infect numerous cell lines (4, 5).  A widely used 
in vitro model of Cryptosporidium infection involves infecting the human colorectal 
carcinoma cell line HCT8 with the human pathogen C. parvum.  In this system, after 
initial asexual replication, the gamonts start to emerge at 36 hours post-infection (hpi) 
and they are the predominant parasitic form at 72 hpi (6-8).  However, fertilization does 
not take place within this system, and parasite replication therefore halts after sexual 
differentiation (7).  Parasitophorous vacuoles of all life cycle stages of C. parvum can 
be stained with Vicia villosa lectin (VVL).  Previously, we have also reported a marker 
protein for female gamonts, DNA meiotic recombinase 1 (DMC1), that can be 
visualized by immunostaining (6).  As both male and female gamonts emerge within a 
similar temporal window post-infection, we used DMC1 expression as a surrogate for 
C. parvum sexual differentiation and developed an assay to test the activity of drug-like 
small molecules against sexual stages of the parasite.  Several anticryptosporidial 
compounds, initially identified by screening using Vicia villosa lectin staining, showed 
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a diverse range of activity against the sexual stage of the parasite (6).   
Like C. parvum, all the apicomplexan parasites cyclically differentiate into 
distinct forms in the course of their complete life cycle.  Each of the stages has its own 
signature global gene expression pattern (7, 9-12).  Molecular understanding of stage 
differentiation could provide an opportunity to develop novel control strategies against 
human pathogens.  Plasmodium species, the causative agents of malaria, first replicate 
in hepatocytes upon infecting humans, then differentiate to infect red blood cells, and 
finally differentiate into gametocytes that are taken up by mosquito vectors where 
sexual reproduction takes place.  Transmission blocking strategies for malaria therefore 
include inhibiting sexual differentiation of Plasmodium, whereas inhibiting the liver 
stage development or its differentiation into the blood-stage would be useful strategies 
for malaria prophylaxis (13, 14).  Fast replicating Toxoplasma gondii tachyzoites 
differentiate into slowly replicating bradyzoites and form tissue cysts in response to 
immune activation in mammalian hosts that can be reactivated upon immune 
suppression.  Intervening with this reversible differentiation could lead to better 
management of toxoplasmosis (15).  C. parvum is different from Plasmodium and 
Toxoplasma in the sense that it can complete its whole life cycle within a single 
mammalian host where its sexual differentiation is believed to be an obligatory step (as 
opposed to the facultative gametocytogenesis observed for P.  falciparum where only a 
small subset of total parasites actually differentiate into gametocytes).  Therefore, 
inhibiting Cryptosporidium sexual differentiation may be a good therapeutic strategy 
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(8).   
Apicomplexan stage differentiation has been studied with several 
complementary experimental approaches.  Comparative “-omics” analyses between life 
cycle stages are useful in identifying stage-specific genes and pathways (16-19).  
Genetic manipulations, either through forward genetic screens or through targeted 
manipulation of key regulators of differentiation, have also been used to study the 
regulation of apicomplexan life cycle progression (20-24).  Finally, chemical biology 
approaches have identified numerous tool compounds to study specific aspects of 
apicomplexan biology (25).   
In this study, we have used a chemical genetics approach in combination with 
mRNA-seq to better understand the regulation of C. parvum sexual differentiation.  We 
optimized a high content microscopy screening assay based on DMC1 expression, and 
screened the ReFRAME (Repurposing, Focused Rescue, and Accelerated Medchem) 
chemical library (26) in order to identify compounds that affect C. parvum sexual 
differentiation.  The ReFRAME library is a library of ~12,000 compounds with high 
potential for drug repurposing, and, since the mechanism of action of many ReFRAME 
library compounds is known, we reasoned that this approach would enable us to gain 
mechanistic insights into C. parvum sexual differentiation.  We then followed screening 
hit confirmation with mRNA-seq experiments in the presence or absence of selected 
differentiation inhibitors.  Our results indicate that transcriptional repression of proteins 
involved in ribosome biogenesis is necessary for C. parvum sexual differentiation.   
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2.3:  Results 
2.3.1:  Optimizing the Identification of Sexually Differentiated C. parvum 
Immunostaining DMC1 protein was used to identify sexually differentiated C. 
parvum.  In order to maximize the sexual differentiation of the parasite and optimize 
the identification of DMC1 expressing (DMC1+) parasites in the HCT8 cell infection 
model, we made several modifications to our standard culture, staining, and image 
analysis methods.  Key changes included supplementing the media with 1% serum 
instead of 10% serum, addition of the antifungal compound Amphotericin B, using 1% 
BSA instead of 4% BSA as blocking solution during immunostaining, and creating an 
image mask for all the parasites in the culture (identified by VVL staining) before 
locating high DMC1 signal during automated parasite counting.  In the end, we 
managed to obtain a good signal-to-noise ratio for the DMC1+ parasites at 72 hours 
post infection (hpi) (Figure 1A).  The Z’ score, an indicator of assay quality (27), was 
consistently > 0.7 for the identification of DMC1+ parasites when using “no primary 
antibody” staining as our negative control.   
The DMC1+ parasite ratio detected with this method at 48 hpi was almost zero 
when using a 0.45 NA objective as is needed for screening with our automated 
microscope (Figure 1B).  We note that other studies reported a higher proportion of 
female gamonts at 48 hpi when detected using other methods (7, 8), and, in our 
previous study, we also detected a higher proportion of DMC1+ parasites at 48hpi when 
visualized through an objective with more resolving power (6).  The ratio of sexual 
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stage parasites to total parasites that we detected with the current method at 72 hpi was 
very similar to all the prior reports (6-8).  This indicated that DMC1 needs to be highly 
expressed to be detected by our screening method, suggesting that it detects only 
relatively mature female gamonts. 
For compound library screening, we devised a strategy in which we tested each 
compound in three separate conditions and considered four separate readouts (two 
asexual growth readouts and two sexual stage specific) (Figure 1C).  The asexual stage 
specific readouts were calculated by counting the total number of parasites at 48 and 72 
hpi following the addition of compounds at 3 hpi.  The number of parasites was 
expressed as a ratio to the number of host cell nuclei to control for host cell 
cytotoxicity, and the effect of compounds on parasite growth was calculated as percent 
inhibition relative to vehicle control-treated wells on each assay plate.  The sexual stage 
specific conditions and readouts were as follows:  1) addition of compound at 3 hpi and 
determination of the ratio of DMC1+ parasites at 72 hpi; and 2) addition of compound 
at 48 hpi (when very few DMC1+ parasites are detectable) with the determination of the 
ratio of DMC1+ parasites at 72 hpi.  We reasoned that compound addition at 3 hpi 
would allow us to identify compounds that inhibit sexual differentiation but minimally 
impact asexual replication.  Note that this readout identified compounds that affect the 
commitment to differentiate with minimal effect on asexual growth, but for compounds 
that inhibit asexual growth, it yielded little useful information about differentiation due 
to low parasite numbers.  The second sexual stage specific readout with compound 
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addition at 48 hpi addressed this, since it identified compounds that inhibit the 
development of female gamonts following the commitment to differentiate 
independently of the compound’s effect on asexual growth.  
2.3.2:  Screening and Validation of the ReFRAME Library  
Using the combined stage specific assay strategy, we screened the ReFRAME 
compound library at 2 µM concentration.  We had multiple DMSO control wells in 
each plate as well as two wells of known inhibitor control nitazoxanide.  Each 
compound’s activity for each readout was determined by normalizing the parasite 
counts with that of the DMSO wells from the same plate.  In the end, we determined 
the average activity and the standard deviation for all the compounds in the library in 
each readout and compounds showing activity two standard deviations above or below 
the library mean were denoted as hits in each readout (Figure 1D and 1E).  For initial 
follow up on compounds meeting this hit definition for at least two of the four 
screening readouts, we used resupplied compounds to conduct eight-point dose 
response assays, ranging from 50 nM to 10 µM for each assay readout (a total of 311 
compounds). 
The compounds roughly fit into seven different categories based on the dose 
response curves (Figure 2A). 42 compounds showed inhibitory activity in all four 
readouts with similar potency.  These were denoted as pan-inhibitors, and were felt to 
be the most straightforward drug-like compounds for the potential treatment of 
cryptosporidiosis (Figure 2B).  70 compounds showed no dose-dependent activity in 
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any of the readouts and were considered false positives from the screening (Figure 2C).  
All the other compounds were differentially potent among the readouts and together 
they constitute a diverse set of tool compounds for studying the C. parvum life cycle.  
The most common theme (accounting for 102 compounds) was similar potency for 
inhibition of all readouts except for inhibition of DMC1+ parasites upon addition at 48 
hpi (Sexual Readout 1 in Figure 1C).  These compounds were either completely 
inactive in this readout (Figure 2D) or showed dose dependent activity that failed to 
reach complete inhibition at the highest tested concentration (Figure 2E).  We 
categorized these compounds as asexual inhibitors.  On the other hand, 23 compounds 
were highly potent against the sexual stage when added at 3 hpi, but had little effect in 
the other conditions/readouts (Figure 2F).  These compounds were categorized as 
differentiation inhibitors and were the predominant focus of our follow up experiments.  
A further 9 compounds showed a narrow but discernable specificity also in the sexual 
differentiation readout (Figure 2G).  19 compounds induced sexual differentiation 
(Figure 2H) or sexual development (Figure 2I) or both (Figure 2J) at concentrations 
that were not inhibitory to asexual stages in a dose dependent manner.  We did not 
classify 46 compounds in any of the above-mentioned categories mainly because they 
were not tested in all conditions or their dose response curves seemed to be in the 
exponential phase and did not reach the above 80% inhibition threshold at the highest 
concentration tested (Figure 2K).  Interestingly, a particular differentiation inducer, the 
Endothelin A receptor agonist S-1255, highly induced the expression of DMC1 at 48 
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hpi, which was unique among all the compounds that we tested (Figure 2L). 
Supplementary Table 1 contains the SMILES structures of all compounds tested in 
follow up, their putative targets and how they were categorized.  Supplementary Figure 
1 contains their dose response curves for each assay readout. 
2.3.3:  Several Differentiation Inhibitors Share Common Modes of Action and 
Activity Kinetics 
The compounds categorized as differentiation inhibitors completely inhibited 
the emergence of DMC1+ parasites in a dose dependent manner.  However, they did not 
completely inhibit asexual parasite growth at any concentration tested (Figure 2F).  All 
23 of them had minimal or no effect on DMC1 expression when added at 48 hpi, 
suggesting that they worked by inhibiting early steps in the differentiation pathway.  
Interestingly, four of them were mitochondrial electron transport chain inhibitors 
(Figure 3A), five of them were inhibitors of nucleotide biosynthesis (Figure 3A, 3B), 
and two of them were fumagillin analogs that covalently inhibit methionine 
aminopeptidase 2 (Figure 3A).  Interestingly, the confirmed asexual stage inhibitors 
also included compounds that inhibit nucleotide biosynthesis, but the putative targets of 
differentiation inhibitors were exclusively involved in the synthesis of purine 
nucleotides (Figure 3B).  
We decided to further probe the mechanisms underlying C. parvum sexual 
differentiation using several of these tool compounds.  We purchased seven 
differentiation inhibitors from independent sources and two were resupplied from the 
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ReFRAME library (Figure 3A).  These nine compounds were selected because they 
showed a highly selective inhibitory activity against sexual differentiation for a wide 
range of concentration.  We first tested a broader range of concentrations for each for 
the condition 2 readouts, which reconfirmed the initial dose dependent characterization 
for all nine compounds (Figure 3C). 
Previous experiments looking at C. parvum life cycle stages at different time 
points post infection suggest that sexual differentiation takes place between 36 and 48 
hpi (7, 8).  This view is consistent with our observation that all the differentiation 
inhibitors were highly efficacious in inhibiting sexual differentiation when added 3 hpi, 
but ineffective to do so when added 48hpi.  While this roughly indicates that they need 
to be added before the differentiation takes place, we wanted to test this phenomenon 
with a higher temporal resolution.  To probe if there is a temporal window when the 
differentiation inhibitors need to be present to exert their effect, we added the nine 
retested differentiation inhibitors at 3, 12, 24, 34 or 48 hpi, and determined the ratio of 
DMC1+ parasites at 72 hpi (Figure 4A).  Six compounds showed highly efficacious 
dose dependent activity when added up to 34 hpi. On the other hand, three compounds 
(i.e. pralatrexate, mycophenolate, and TVB-2640) lost that activity if added at or after 
24 hpi (Figure 4B), suggesting that prolonged exposure was required and/or that they 
affect early stages of differentiation such as commitment.  Nitazoxanide, which was 
classified as a pan-inhibitor, had the same effect regardless of the timing of addition.  
This was consistent with the likelihood that pan inhibitors have a general toxic effect on 
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C. parvum growth that is independent of the stage of the parasite’s life cycle.     
2.3.4:  mRNA-seq Analysis of Compound Effects on Gene Expression 
To gain insights into the genetic regulation of Cryptosporidium sexual 
differentiation, we examined the effects of selected differentiation inhibitors on parasite 
and host gene expression using mRNA-seq and the C. parvum HCT8 cell culture 
system.  A suitable time point was first determined by conducting mRNA-seq in the 
absence of differentiation inhibitors at 18, 36, 48, and 72 hpi.    We aligned the 
sequencing reads with both human and C. parvum genomes using HISAT2 (28), 
created separate subsets of alignment files uniquely aligned to the parasite or host 
genome, counted the number of alignments per gene using HTseq (29), and finally 
performed differential gene expression analysis using DEseq2 (30).  Genes with ≥ 2-
fold expression difference at a 10% false discovery rate (FDR) were considered as 
differentially regulated. Overall, very few parasite genes were differentially regulated 
between the 18 and 36 hpi samples, but a large number of genes were differentially 
regulated between the 36 and 48 hpi samples and the 48 and 72 hpi samples.  On the 
other hand, a relatively small number of host genes were differentially expressed 
(Figure 5A).  Given these data, we selected the 48 hpi timepoint for the transcriptomic 
analysis of the differentiation inhibitor treatments in subsequent experiments.  Each 
compound was used at a dose that was previously found to be highly selective for 
sexual differentiation (see Figure 3C), and mRNA-seq libraries were prepared at 48 hpi 
after each of the compounds or vehicle were added at 3 hpi (Figure 5B)(2 biological 
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replicates each, except for pralatrexate (n=1) for which library preparation failed for 
one replicate).)  
Compound treatment affected both host and parasite gene expression (Figure 
5B).  The two methionine aminopeptidase2 inhibitors, AGM-1470 and Beloranib 
hemioxalate, very selectively dysregulated parasite gene expression, whereas the 
inhibitors of oxidative phosphorylation and mubritinib dysregulated a high number of 
host genes.  We also performed the differentiatial gene expression analysis using the 
the combined expression count files of the host and the parasite genes together, which 
also confirmed the predominantly parasite-specific dysregulation of genes by the 
MetAP2 inhibitor AGM-1470 (Supplementary figure 2).  Note that in these 
experiments the proportion of infected and uninfected host cells varied with time point 
and compound treatments, which complicated comparative analysis of host gene 
expression.  We have therefore not performed any detailed analysis on host gene 
expression beyond determining the number of affected genes in the host transcriptome. 
There was a high degree of identity between genes that were dysregulated by 
the various differentiation inhibitor treatments (Figure 5C, 5D).  Supplementary Table 
2 contains the fold changes of parasite genes that met the threshold of statistical cutoff 
(FDR <0.1).  As the nine differentiation inhibitors act upon eight different target 
proteins, the uniquely dysregulated genes are highly likely to be compound specific 
effects.  In contrast,  as all our nine tested compounds causes the same effect of sexual 
differentiatiaon inhibition, commonly dysregulated genes by multiple treatments might 
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be more involved in regulating the sexual differentiation.  In line with this reasoning, 
we compiled a list of parasite genes that were dysregulated with the majority (at least 
five or more) of the compound treatments.  We compared this gene list with the list of 
significantly dysregulated genes identified through RNA-seq between C. parvum 
asexual and female stage parasites separated by flow cytometry.  Our commonly 
upregulated gene set was highly similar to the gene set overexpressed in the asexual 
stage compared to female stage and our commonly downregulated gene set had a high 
degree of similarity with the genes overexpressed in the female parasites 
(Supplementary figure 3), which validates our dataset and our approach of selecting 
stage-specific genes.  
2.3.5:  Female-specific Genes are Down-regulated and Asexual Stage-specific 
Genes are Upregulated Following Treatment with Differentiation Inhibitors 
Life cycle stage specific gene expression is a well-documented phenomenon in 
apicomplexan parasites.  We wanted to check if the dysregulated genes from the 
compound treated samples were stage specific or not.  To putatively identify stage 
specific genes, we have used two relevant RNA-seq datasets available in the EUpathdb 
database (31), one for C. parvum and the other one for Plasmodium.  The Plasmodium 
dataset compared gene expression patterns between the asexual blood stage, and male 
and female gametocytes (18).  We selected Plasmodium genes that are differentially 
expressed between these stages (FDR<0.1; log2 fold change of ≥1).  Genes that are 
upregulated in the asexual stage compared to gametocytes were denoted as asexual 
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stage specific genes.  Genes that are upregulated in both gametocytes or in one of the 
gametocytes compared to asexual stage were denoted as gametocyte, male and female 
specific genes accordingly.  Ortholog transformation of each of these gene sets 
identified their homologs in the C. parvum genome, and was used to enable comparison 
of C. parvum and Plasmodium data.   The Eupathdb C. parvum dataset contains the 
gene expression pattern for FAC sorted asexual stage parasites and female gamonts (7).  
Using the same cutoffs for differential expression, we identified asexual and female 
specific genes using this dataset.  If any gene was putatively identified as asexual stage 
specific or male specific based on the Plasmodium database but marked as female 
specific from the C. parvum dataset or vice versa, we denoted them as divergent genes.  
All the other genes without any stage specific expression were denoted as unresolved.  
This set of genes most likely encode proteins that perform essential functions 
throughout the life cycle of C. parvum. 
After using these existing datasets to classify all of the C. parvum genes as 
above, we checked if there was any stage specificity in the differentially expressed 
genes identified following compound treatments.  All the compounds showed a similar 
pattern in our analysis; asexual stage specific genes were upregulated and female stage 
specific genes were downregulated due to compound treatment (Figure 5E, 
Supplementary Figure 2).  We did not observe any strong effect in the other classes of 




2.3.6:  Proteins Involved in Ribosome Formation are Upregulated in Response to 
Differentiation Inhibitors 
We performed functional annotation enrichment analysis of the upregulated and 
downregulated gene sets following treatment with all of the differentiation inhibitors 
using DAVID Bioinformatics Resources 6.8 (32).  As there was a high degree of 
similarity between gene sets dysregulated by the different compound treatments, the 
functional annotation enrichment analysis identified similar gene classes enriched with 
all the treatments (Supplementary Table 3).  Therefore, to limit the analysis to common 
pathways involved in differentiation and exclude potentially misleading effects seen 
with individual compounds, we repeated the analysis with gene sets significantly 
dysregulated (FDR<0.1) following treatments with the majority of the compounds (five 
out of nine treatments).  We noticed that for the genes that were significantly 
dysregulated with multiple treatments, the log2 fold-change was often marginally 
below 1 for some treatments, so this cutoff likely resulted in the erroneous exclusion of 
some biologically relevant differentially expressed genes in the combined gene sets.  
Therefore, we bypassed setting a fold change cutoff for selecting commonly 
dysregulated genes and selected them only based on the FDR cutoff, which provided a 
better representation of all the different compound treatments.  Following treatment 
with differentiation inhibitors, this analysis indicated that genes encoding proteins 
associated with ribosome biogenesis and structure were commonly upregulated, 
whereas genes encoding proteins involved with biosynthesis of secondary metabolites 
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and glycolysis were commonly downregulated (Figure 6A). 
We wanted to check whether the upregulation of ribosomal genes was just a 
response to compound treatment or represented biologically relevant differential 
expression between C. parvum life cycle stages.  For this, we reanalyzed the Eupathdb 
C. parvum dataset comparing the female and asexual transcriptomes to determine 
whether the functional annotation enrichment analysis of our dataset correlated with 
that dataset or not (7).  As compound treatment inhibited sexual differentiation, genes 
upregulated with compound treatment should be downregulated in female gamonts 
when compared with the asexual stage and vice versa.  Similarly, genes involved in 
glycolysis should be upregulated in female gamonts.  Analysis of the existing C. 
parvum dataset confirmed these predictions (Figure 6A).  Furthermore, ribosomal genes 
were the most significantly downregulated gene class in female gametocytes, strongly 
suggesting that modulating ribosome formation could be a key regulatory mechanism 
for parasite differentiation. 
We plotted the actual average transcript per million (TPM) values of all the 
genes that code for proteins that are structural components of the ribosome.  This 
indicated that mRNAs encoding this class of proteins reached their peak concentration 
at 36 hpi and then decrease rapidly at 48 and 72 hpi (Figure 6B).  Compound treatment 
inhibited the repression of most of the members in this gene set.  Interestingly, 
hierarchical clustering of the expression pattern of this gene set clustered the compound 
treated samples (prepared from 48 hpi) with 18 hpi and 36 hpi control samples whereas 
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the 48 hpi control sample clustered with 72 hpi control sample (Figure 6B). 
Ribosomal protein genes are scattered across the C. parvum genome, yet the 
mRNA levels were highly correlated with each other across time points and compound 
treatment.  This prompted us to search for conserved sequence signatures within the 
upstream and downstream regions of these genes.  Differential enrichment analysis of 
the upstream region of the ribosomal protein genes identified a DNA motif, 
BYGTCTC, that was highly enriched in these genes compared to all the annotated 
protein coding genes of C. parvum (Figure 6C).  Other than the ribosome structural 
proteins (n=78), the motif was found in the promoter region of 455 additional genes.  
We checked if those genes were consistently upregulated or downregulated 
(dysregulated in >=5 compound treatment), and, based on a Chi-square test, the motif 
was more commonly found in the promoter region of genes upregulated following 
treatment with differentiation inhibitors (Figure 6D).  Furthermore, analysis of the 
motif’s location indicated that it is typically located closer to the start codon for genes 
coding for ribosomal structural proteins and genes that were consistently upregulated, 
and is generally distally placed for the genes that were downregulated following 
compound treatment (Figure 6E).  A comparison of the downstream sequences of 
ribosomal genes with other C. parvum genes did not identify significantly enriched 





2.3.7:  Ribosomal Proteins are Generally Downregulated in Response to 
Translational Repression Programs During Differentiation in Apicomplexan 
Parasites 
Our mRNA-seq dataset indicated that ribosomal protein genes are 
downregulated during C. parvum sexual differentiation.  We checked if this is a 
common mechanism of regulating differentiation in apicomplexan parasites by using a 
variety of datasets available via Eupathdb to identify genes that are upregulated or 
downregulated in different life cycle stages of other apicomplexan parasites 
(Supplementary Table 4) (11, 18, 33-36).  In Plasmodium, ribosomal genes are 
downregulated during female gametocytogenesis as well as in salivary gland 
sporozoites compared to midgut oocysts.  In T. gondii, ribosomal genes are 
downregulated in bradyzoites compared to tachyzoites (Figure 6F).  Interestingly, in all 
the three above mentioned differentiation axes, mechanistic studies indicate that post 
transcriptional repression of gene expression plays a critical role in the differentiation 
process.  During maturation of P. berghei female gametocytes, overexpressed mRNAs 
are protected at the cytoplasmic P bodies, which also repress their translation (37, 38).  
In Plasmodium salivary gland sporozoites, inhibitory phosphorylation of eukaryotic 
translation initiation factor alpha (eIF2α) represses the translation of mRNAs (39).  The 
T. gondii eIF2α is also observed to be phosphorylated in bradyzoites (40, 41).  
Collectively, these publications indicate that the repression of ribosomal proteins 
correlates with a translational repression program in Plasmodium and Toxoplasma.  In 
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Eimeria, ribosomal genes are upregulated in merozoites compared to both sporozoites 
(the earlier stage) and gametocytes (later stages) (Figure 6F).  Overall, in all the three 
apicomplexan parasites where sexual and asexual stage gene expression has been 
compared with RNA-seq, ribosomal proteins are enriched in gene sets that are 
downregulated in sexual stages. 
2.3.8:  The DNA Recognition Motif of Four ApiAp2 Transcription Factors is 
Significantly Enriched in the Promoter Regions of Commonly Downregulated 
Genes  
Genes that are commonly downregulated with five or more differentiation 
inhibitor treatments are potentially overexpressed during or after sexual differentiation.  
Specific regulatory DNA sequences might control their sexual stage specific expression 
pattern.  To identify such potential regulatory elements, we screened the promoter 
regions of these genes for significant enrichment of DNA motifs.  We found that the 
motif “CATGCAWH” is the most significantly enriched DNA motif in the promoter 
region of these genes (Figure 7B). 
The family of apicomplexan AP2 transcription factors (TFs) has been 
extensively studied in Plasmodium parasites and several of them have been implicated 
in regulating parasite differentiation in the course of its life cycle (21, 22).  There are 18 
putative ApiAP2 TFs in the C.  parvum genome based on sequence similarity to the 
AP2 DNA binding domain (42).  Previously, using DNA binding microarray, the 
putative DNA recognition motifs of several C. parvum AP2 TFs were identified (42).  
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Interestingly, the “CATGCAWH” motif that is significantly enriched in the promoters 
of our downregulated gene set bears a high degree of similarity to the recognition site 
of four different ApiAP2 TFs (listed in Figure 7A).  Two of these TFs (cgd8_3230 and 
cgd2_3490) themselves are also significantly dysregulated by five or more 
differentiation inhibitor treatments (Figure 7A), which suggests that they might play 
key regulatory roles in controlling the expression of sexual stage specific genes in C. 
parvum.   
2.4:  Discussion 
In this study, we have tested the ReFRAME library, a diverse set of biologically 
active compounds, for activity against the sexual and asexual phases of the C. parvum 
life cycle.  We identified compounds with differing modes of activity against the two 
life cycle stages and performed detailed transcriptomic analyses of a set of compounds 
that selectively affect the parasite sexual differentiation.  We identified that proteins 
involved in ribosome formation are transcriptionally downregulated as parasites 
differentiate into sexual stage and treatment with differentiation inhibitors negatively 
affects this mode of regulation.  In addition, we found that an experimentally validated 
binding site of several C. parvum ApiAP2 TFs is significantly enriched in the promoter 
region of genes that are downregulated with multiple differentiation inhibitor 
treatments, which indicates that these TFs play key regulatory roles in C. parvum 
sexual differentiation.    
The compounds in the ReFRAME library were initially developed to treat a 
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variety of diseases, with a bias towards cancer therapeutics.  Respiratory, 
cardiovascular, and CNS conditions are also highly featured amongst the disease 
indications; altogether these indications account for ~86% of ReFRAME compounds, 
which were primarily developed to treat human conditions not caused by infectious 
agents (26).  Therefore, many ReFRAME compounds target human proteins or RNAs.  
As an intracellular parasite, C. parvum must be sensitive to the altered condition in the 
host cells.  It is therefore highly likely that a lot of validated hits from our screen are 
acting on C. parvum by altering the host cell condition, without directly targeting 
parasite proteins.  A prime example of such mode of action is the four identified 
compounds that likely inhibit parasite sexual differentiation by acting on mitochondrial 
function (Figure 3A).  C. parvum does not contain a fully functional mitochondrion 
itself; instead, it harbors a relict mitochondrion without a genome that is termed a 
mitosome (43).  Consistent with a primary effect on the host cell, the two of the 
mitochondrial inhibitors included in our RNA-seq analysis caused dysregulation of a 
high number of host genes in addition to parasite genes (Figure 5B).  This strongly 
suggests that host cell mitochondrial function is critical for parasite life cycle 
progression and its dysregulation affects the parasite sexual differentiation more 
profoundly than general growth.  Interestingly, media removal to the establish an air-
liquid-interface (ALI) condition during the culture of stem cell derived mouse intestinal 
epithelial cells supports the continuous cultivation of C. parvum in vitro (44).  Parasite 
vacuole number significantly increases under the ALI condition from two days onwards 
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post infection compared to non-ALI condition, and, in contrast to the HCT8 culture 
system, both fertilization and production of infectious oocysts occurs.  Consistent with 
our finding that inhibitors of the host cell mitochondrian block C. parvum sexual 
development, host cell RNA-seq comparison of the ALI and non-ALI conditions 
identified oxidative phosphorylation as the most significantly upregulated pathway 
under ALI conditions (44). 
Targets of five differentiation inhibitors are enzymes of interconnected folate 
metabolism and purine nucleotide biosynthetic pathways (Figure 3A, 3B).  We persued 
two of these in our follow up experiments, pralatrexate, an inhibitor of mammalian 
dihydrofolate reductase (DHFR) (45), and mycophenolate mofetil, a prodrug that is 
converted into mycophenolic acid, which inhibits host inosine-5'-monophosphate 
dehydrogenase (IMPDH) (46).  Recently, it has been shown that knocking out several 
of the C. parvum proteins involved in nucleotide salvage, including DHFR-TS 
(cgd4_4460) and IMPDH (cgd6_20), has no effect on the replication of C. parvum 
(tested for 48 hpi) (47).  However, unlike WT parasites, these mutants are susceptible 
to pharmacological inhibition of relevant host nucleotide synthesis.  Interestingly, both 
of these enzymes are significantly upregulated at 72 hpi compared to 48 hpi in vehicle 
treated C. parvum infection, which suggests an increased need for nucleotides during 
the parasite sexual stage (Supplementary Table 2).  Phenotypes of nucleotide salvage 
pathway knockout mutants of C. parvum suggest that the parasite has redundant 
pathways to synthesize pyrimidine nucleotides but not purine nucleotides, which makes 
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them comparatively more dependent on the host for purines. As a likely cause of this 
duplicity, it has been proposed that host derived purine nucleotides are directly 
imported as ATP that fulfills the energy demand of the parasites in addition to serving 
as nucleic acid building blocks (47).  As discussed later, our data suggest that in the 
sexual stage, either energy demand is more or access to the host nucleotide pool is 
reduced compared to asexual C. parvum.  This might be the reason why the sexual 
stages of the parasite are disproportionally affected by inhibitors of host purine 
biosynthesis compared to asexual stages.  Interestingly, both of the retested nucleotide 
biosynthesis inhibitors affected sexual differentiation only when added at 3hpi and 
12hpi, but failed to completely do so when added later (Figure 4B).  Perhaps the host 
ATP pool is sufficiently depleted for inhibition of sexual differentiation only with 
prolonged exposure of these compounds. 
AGM 1470 and beloranib are fumagillin analogs that covalently bind to human 
methionine aminopeptidase 2 (MetAP2) (48).  MetAP2 is a bifunctional protein and 
one of its functions is to remove the N-terminal methionine from nascent proteins.  
Fumagillin analogs covalently bind to a histidine residue in the active site of MetAP2 
and block this function (48).  The active site histidine and the surrounding residues are 
conserved in C. parvum MetAP2.  The other function of MetAP2 is to bind and protect 
the eukaryotic translation initiation factor 2 alpha (eIF2α) from inhibitory 
phosphorylation (49).  eIF2α plays a critical role in the rate-limiting step of translation 
initiation, and the phosphorylation of eIF2α inhibits this activity (50).  Several kinases 
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phosphorylate eIF2α in response to diverse types of stresses (51).  Covalent binding of 
the fumagillin analogs does not directly alter this second function of MetAP2; however, 
they can indirectly enhance this function as the covalent modification of the protein 
enhances its stability (52, 53).  Treatment with these compounds significantly 
dysregulated a high number of parasite genes, but, compared to the other differentiation 
inhibitors, a very small number of host cell genes (Figure 5B).  Therefore, while we 
cannot formally reject the possibility that these fumagillin analogs affect C. parvum 
through effects on host metAP2, it is highly likely that their effect on parasite sexual 
differentiation results from inhibiting the parasite enzyme.        
Consistent with this possibility, regulation of eIF2α phosphorylation is 
implicated in controlling stage differentiation in both Plasmodium and Toxoplasma.  T. 
gondii eIF2α phosphorylation is necessary for tachyzoite to bradyzoite differentiation 
(40, 41, 54-56).  In Plasmodium, several proteins required for the liver stage are 
actually transcribed in salivary gland sporozoites, but their translation is repressed (19, 
57, 58).  IK2, a kinase of eIF2α, is critical for this translational silencing (39, 59).  Even 
though MetAP2 has been implicated in the protection of eIF2α, its role has never been 
specifically investigated in apicomplexan eIF2α phosphorylation regulation of stage 
differentiation.  As MetAP2 inhibitors inhibit the sexual differentiation of C. parvum 
and the transcriptional signature of this differentiation inhibition mimics translational 
silencing in apicomplexan parasites (Figure 6F), it is likely that these fumagillin 
analogs inhibit C. parvum sexual differentiation by inhibiting parasite eIF2α 
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phosphorylation (Figure 8).  In this model, normal sexual differentiation requires 
phosphorylation of parasite eIF2α, which turns on a translational silencing program in 
the parasites.  AGM 1470 and beloranib bind and stabilize parasite MetAP2, which 
leads to increased protection of eIF2α from inhibitory phosphorylation.  As a result, the 
translational silencing program fails to activate and sexual differentiation is inhibited. 
Among the compounds that induced sexual differentiation or development, 
common putative targets include DNA topoisomerase (four compounds), cyclin 
dependent kinases (cdks, three compounds), and Aurora kinases (two compounds).  
And among other validated hits, two cdk inhibitors are classified as pan-inhibitors and 
two others as asexual inhibitors.  Similarly, five putative topoisomerase inhibitors and 
two aurora kinase inhibitors are classified as asexual stage specific inhibitors 
(Supplementary Table 1).   
The purpose of the RNA-seq experiments reported here was to identify sexual 
and asexual stage specific genes and pathways, some of which might be involved in 
regulating C. parvum sexual differentiation.  We selected compounds with diverse 
structures and putative targets for this study, all of which cause the same effect, i.e. 
inhibition of sexual differentiation (Figure 3A).  For each of the compounds, we 
selected a dose that highly and preferentially inhibits differentiation (Figure 3B).  We 
reasoned that with such a high effective dose for a particular phenotype, dysregulated 
genes and pathways common in the majority of the treatments would be parasite life 
cycle stage specific elements, as opposed to compound specific dysregulated elements.  
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Indeed, there was a high degree of commonality in dysregulated genes (Figure 5C and 
5D, supplementary table 2).  According to our experimental design, asexual stage 
specific genes should be upregulated and sexual stage specific genes should be 
downregulated following treatment with the differentiation inhibitors.  We compared 
the consistency of our approach with the previously published complementary approach 
of conducting RNA-seq on FAC sorted parasites using a female gamont-specific 
promoter driven reporter to separate asexual and female sexual stage specific parasites 
(7).  To include the male stage specific gene expression in our comparison, we 
interpolated stage specificity of C. parvum genes from a similar FAC sorting-based 
dataset of Plasmodium (18).   A high degree of correlation between our dataset and the 
two other datasets validates our approach (Figure 5E).  At the same time, it also 
indicates that the sexual stage specific gene expression pattern is reasonably conserved 
between Plasmodium and Cryptosporidium. 
Functional annotation enrichment analysis of commonly dysregulated genes 
identified (dysregulated in ≥5 compound treatments) glycolysis as the most highly 
enriched pathway in the downregulated gene set and ribosome biogenesis in the 
upregulated gene sets (Figure 6A, Supplementary Table 3).  The result of this analysis 
is consistent with the same analysis performed for dysregulated gene sets between 
asexual and female gamonts (Figure 6B).  In the absence of a fully functional 
mitochondrion, glycolysis is considered to be the main energy generating pathway for 
C. parvum.  As our data indicate that this pathway is more active following sexual 
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differentiation, we propose two mutually non-exclusive models to explain this stage 
specific energy metabolism in C. parvum.  One is that the energy demand in sexually 
differentiated parasites is simply higher compared to the asexual stages.  That can arise 
from the necessity of producing residual bodies, a type of energy storage structure 
composed of carbohydrates and other metabolites that are observed in both 
macrogamonts and oocysts (60, 61).  Another possibility is that the sexual stages are 
less efficient in importing energy equivalents from the host, which is compensated by 
increased energy production by the parasite itself.  As mentioned above, it has been 
proposed that C. parvum might harbor transporters that directly take up ATP from the 
host cell (47).  Stage specific differences in the abundance of such a transporter might 
reduce energy uptake from the host cell following sexual differentiation.  Overall, each 
model is consistent with our observations that inhibition of host oxidative 
phosphorylation and purine biosynthesis both affect sexual differentiation. 
The upregulation of ribosome biogenesis and structural proteins following 
differentiation inhibitor treatments suggests an overall lower rate of protein synthesis in 
sexually differentiated parasites (Figure 6A and 6B).  This persuaded us to look for 
similar transcriptional dysregulation patterns in other apicomplexans, as translational 
repression is a well-documented mechanism of regulating stage differentiation in 
apicomplexans.  In all three differentiation axes where translational silencing has been 
validated with genetic experiments, the same ribosomal dysregulation signature has 
been observed (Figure 6F).  Collectively, this strongly associates the downregulation of 
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ribosomal genes in RNA-seq datasets with the establishment of a translational silencing 
program.  Without further experimental validation, however, it is unclear if the 
downregulation of ribosomal genes is causative for translational silencing or if the 
establishment of translational silencing somehow causes the transcriptional 
downregulation of ribosomal genes.  Downregulation of ribosomal proteins is also 
observed in Eimeria gametocytogenesis; however, no mechanistic experiment to 
determine the regulation of this differentiation has been published.  
One important point to note here is that all the apicomplexan parasites 
obviously possess stage specific proteins that are overexpressed under these general 
transcriptionally silenced and impaired-ribosome-biogenesis conditions.  How the 
expression of those proteins is enhanced under such a condition is an important 
research question.  Perhaps the answer is contained in the fact that ribosomes are not 
homogenous structures that keep translating all the mRNAs at a constant rate.   Rather, 
they are heterogeneous structures that vary in building blocks between cell types and 
conditions, and they can selectively translate certain mRNAs over others (62).  It would 
be interesting to experimentally test if such “special ribosomes” play a key regulatory 
role in apicomplexan stage differentiation. 
Differential enrichment of mRNAs between conditions can result from their 
altered transcription or stability.  In our RNA-seq follow up analysis, we focused on 
transcriptional regulation by looking at the putative promoter regions of C. parvum 
genes.  We searched for enriched sequence motifs in the promoter region on various 
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subsets of C. parvum genes that are connected by similar dysregulation patterns and/or 
are from the same pathway or protein class.  We identified very significant enrichment 
of a DNA motif in the upstream region of the ribosomal structure genes (figure 6C).  
This suggests that their transcription is controlled by the same transcriptional regulators 
and putatively explains why these genes are dysregulated as a group (Figure 6B).  The 
other significant promoter motif signal that we observed came from the genes that are 
downregulated in ≥5 compounds treatments (Figure 7B).  Interestingly, a part of this 
motif is identical to the experimentally validated core binding site of four different 
ApiAP2 transcription factors.  TFs of this class are well defined as key regulators of 
apicomplexan stage differentiation.  In both Plasmodium and Toxoplasma, the binding 
sites of multiple AP2 TFs are similar.  They often function antagonistically to each 
other and the expression levels of the genes that they regulate are essentially 
determined by the expression levels of the TFs  (63-65).  Among the four C. parvum 
AP2 TFS that bind to the “TGCAT” core, cgd8_3230 is significantly upregulated in six 
treatments whereas cgd2_3490 is significantly downregulated with eight different 
treatments (Figure 7B).  Combining all this information, we propose that the expression 
of a set of sexual stage specific genes is activated by cgd2_3490 and repressed by 
cgd8_3230.     
Among all the validated hits from our screening, we have only used the 
differentiation inhibitors in this study to better understand the genetic regulation of 
sexual differentiation of C. parvum.  Adding the other classes of hits, specifically the 
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sexual differentiation and development inducers, into the mRNA-seq analysis pipeline 
may further assist in recognizing the key regulatory factors in parasite sexual 
differentiation.  Moreover, there are still numerous open questions about the parasite 
life cycle.  The different classes of compounds identified in this study can be utilized in 
diverse ways to answer some of those questions.  For example, in an animal model or in 
a continuous in vitro culture system, differentiation inhibitors can be used to check if 
sexual differentiation is an obligatory step following several rounds of asexual 
replication, i.e. whether the parasite would die or continue to grow asexually with a 
blockade in sexual differentiation.  Such an experimental design would address the 
druggability potential of C. parvum sexual differentiation and may also lead to the 
identification of tool compounds to facilitate continuous cultivation of C. parvum in a 
simpler culture system than is currently available.  
Before concluding, we would like to mention that as the ReFRAME library is 
biased towards human protein targets, applying a similar screening methodology with a 
less biased library might identify compounds that would more specifically target C. 
parvum proteins.  Additionally, other phenotypic patterns may potentially be caused by 
compound treatment that we have not yet captured.  For example, we have not yet 
identified a selective sexual development inhibitor or a sexual stage specific inhibitor 
that would inhibit both sexual differentiation and development.  The utility of such tool 
compounds would be immense for the mechanistic understanding of C. parvum sexual 
differentiation.   
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2.5:  Material and Methods 
2.5.1:  In vitro C. parvum Infection Model 
Human ileocecal adenocarcinoma (HCT-8) cells (ATCC; catalog# CCL-244) 
were used as host cells for C. parvum infection.  The cells were passaged in modified 
RPMI-1640 medium (Gibco, catalog# A10491–01) supplemented with 10% heat 
inactivated fetal bovine serum (Sigma) and antibiotic solution (120U/mL penicillin and 
120 ug/ml streptomycin; Gibco 15140-122).  Cell culture passage number 9 to 36 were 
used for parasite infection.  C. parvum oocysts were routinely purchased from 
Bunchgrass Farm (Deary, ID) and used for up to 6 months.  To infect HCT8 cells, 
oocysts were excysted in vitro by treating them first with 10mM HCL (37C, 10 
minutes) and then 2mM sodium taurocholate (16C, 10 minutes; Sigma T4009).  Host 
cells are grown to 90% confluency in appropriate plates for infection.  Infection media 
was same as HCT8 culture media except that it was supplemented with 1% serum 
instead of 10% and antifungal compound Amphotericin B (0.625 ug/ml; Sigma A2942) 
was added in addition to the antibiotic solution.  Infected cells are incubated at 37C 
with 5% CO2. 
2.5.2:  Compound Screening and Dose Response Validation 
Host cells were grown in 384 well plates and infected with 5500 oocysts per 
well.  Following infection, compounds were added at appropriate timepoints using 
Biotek Precision microplate pipetting system.  Cultures were washed with wash 
solution (0.1% tween 20 in 1X PBS) 3 times before fixing with 4% paraformaldehyde 
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and permeabilizing with 0.25% triton X-100.  1% BSA was used for blocking before 
staining with Anti DMC1 antibody clone 1H10G7 (hybridoma supernatant).  Plates 
were incubatd at 4c for at-least 24 hours with the primary antibody before washing with 
the wash solution three times, with five minutes incubation between each wash.  
Subsequently, the culture was stained with 4ug/ml Alexa Fluor 568 goat anti-mouse 
IgG (Invitrogen, A-11004) and 1.33 µg/mL FITC-labeled Vicia villosa lectin (Vector 
Laboratories, FL-1231) in 1% BSA for at-least 1 h at 37 °C.  Finally, 0.09 mM Hoechst 
33258 (AnaSpec, catalog# AS-83219) stain was added to stain the nucleus for 10 
minutes.  Then the wells were washed with wash solution five times, with five minutes 
incubation between each wash. 
The culture plates were imaged with Nikon Eclipse Ti2000 epifluorescence 
microscope equipped with automated stage movement, using an objective with 20X 
magnification and 0.45 numerical aperture.  5 by 5 field of views were captured for 
each well.  Images were analyzed with an automated Imagej macro (66) to count the 
number of nucleus, total parasite and DMC1+ parasites. 
2.5.3:  mRNA-seq Sample Preparation and Sequencing 
HCT8 cells were grown to 90% confluence on 24 well plates and infected with 
an appropriate number of excysted oocyst (2, 1, 0.5 and 0.4 million for 18, 36, 48 and 
72 hpi samples respectively) in 1 mL of infection media.  Compound or DMSO was 
added at appropriate time points.  Before RNA isolation, wells were washed 3 times 
with the wash buffer.  Total RNA was isolated using the Qiagen RNeasy mini kit (cat 
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#74104).  Messenger RNA enrichment and sequencing libraries were prepared using 
NEXTFLEX Rapid Directional RNA-seq Library Prep kit bundle (cat # NOVA-5138-
10) following the kit manufacturer’s protocol.  The next-generation sequencing (75 
Base pair single end) was performed in the Vermont Integrative Genomics Resource 
Massively Parallel Sequencing Facility and was supported by the University of 
Vermont Cancer Center, Lake Champlain Cancer Research Organization, UVM 
College of Agriculture and Life Sciences, and the UVM Larner College of Medicine. 
2.5.4:  mRNA-seq Data Analysis 
Sequences were demultiplexed and provided in “.fastq” format by Vermont 
Integrative Genomic Resource core facility.  The sequences were uploaded to the 
public server of the Galaxy web platform (usegalaxy.org) and all the subsequent 
analyses were performed in that server (67).  Sequences were quality trimmed using 
Trimmomatic (68) and then aligned to a combined genome sequence file of Human 
genome (Gencode release 31, GRCh38, (69)) and C. parvum genome (Cryptodb release 
44, C. parvum IowaII, (70)) using HISAT2 (28).  Alignment file was sliced into host 
part and parasite part using the Slice tool and processed separately in subsequent 
operations.  We used HTseq (29) to determine the number of reads aligned to each 
gene.  Deseq2 was used to analyze differential expression between appropriate samples 
(30).  Deseq2 result files were downloaded, relevant values of the genes that met the 




2.5.5:  Pathway Analysis and Gene Expression Heatmap Generation 
Functional annotation enrichment analyses with C. parvum genes were 
performed in DAVID Bioinformatics Resources 6.8 (32, 71).  Appropriate gene ids 
were copied as gene list and CRYPTODB_ID was selected as Identifier type.  All C. 
parvum genes were used as background and all the other options were used as default.  
For other apicomplexan parasites, “analyze result” was used from an appropriate 
apicomplexan parasite database after selecting appropriate genes using gene id search 
(31).  TPM values of C. parvum ribosomal proteins were used to generate expression 
heatmap as well as clustering of samples using shinyheatmap (72).  For clustering, the 
Euclidean distance metric and the “complete” linkage algorithm were used. 
2.5.6:  C. parvum genes’ Upstream and Downstream Sequence Analysis 
1 kb upstream and 1 kb downstream region of all the C. parvum genes were 
uploaded in the usegalaxy.org server.  All the C. parvum coding sequences were then 
used as adapter sequences in the cutadapter tool to remove any coding part from the up 
and downstream sequences of the C. parvum genes.  Such regulatory sequences from 
the selected genes were used as inputs and regulatory sequences from all the C. parvum 
genes were used as background in the “DREME” tool (73) hosted at “MEME-suite” 
server (74) to identify significantly enriched motifs.  Position of specific motifs at the 





2.6:  Figure legends 
Figure 1:  Stage specific assay development and library screening.  A) Two 
replicate experiments showing anti-DMC1 antibody staining is sensitive and specific 
for quantitative screening purposes.  HCT8 cell monolayers grown in 384-well culture 
plates were infected with C. parvum, and then stained for the female gamont-specific 
marker DMC1 at 72 hours post infection (hpi).  The DMC1+ parasite ratio was 
calculated for the 72 hpi timepoint, along with the z’ score for each replicate. N=56 for 
each replicate, 28 each for wells stained with (red) or without (blue) inclusion of anti-
DMC1 antibody.  B) Representative images of HCT8 cells infected with C. parvum and 
stained with flourescent conjugated lectin, anti DMC1 antibody and nuclear stain.  C) 
Combined assay strategy, showing compound addition and imaging timepoints as well 
as the four different readouts. Each readout is normalized to the readout value of 
vehicle treated wells from the same plate to calculate the “percent inhibition” value.  D) 
Statistics of the primary screening for all the four readouts, showing average and 
standard deviation (SD) of the percent inhibition of vehicle-treated wells and inhibitor 
control wells from all the screening plates, as well as all the ReFRAME library 
compounds.  Note that the expected mean percent inhibition by ReFRAME compounds 
with no activity (the vast majority) is 0.  Hits were identified as compounds with a 
percent inhibition differing from the mean for all compounds by over two standard 
deviations.  The cutoff values (library mean ± 2 * Standard deviation) for hit 
identification are given in the bottom two rows.  E) Heatmap showing the result pattern 
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of the primary hits (311 compounds).  Compound activity values are z normalized 
across each readout using the mean and SD of percent inhibitions for all the compounds 
of the ReFRAME library.   
Figure 2:  Categories of the validated hits and example dose response 
curves. A) Pie chart showing categorization of different hits. 2B to 2L show typical 
dose response curves for compounds representative of the different categories.  Each 
point is from a single biological replicate and each curve shows one of the four 
readouts, as indicated in the figure.  B) Pan-inhibitor, C) False hit, D) Asexual stage 
inhibitors without any activity in the sexual development readout, E) Asexual stage 
inhibitors with mid-range efficacy in the sexual development readout, F) 
Differentiation inhibitor, G) Differentiation inhibitor with narrow selectivity, H) 
Differentiation inducer, I) Development inducer, J) Inducer of both sexual readouts, K) 
Compound class undetermined. For 2H and 2J, activity values in the differentiation 
readout are excluded for the doses with above 70% asexual inhibition at 72hpi, because 
at these concentrations very few parasites were present. L) The dose response curve of 
the single compound that induced high DMC1 expression at 48 hours. DMC1+ parasite 
ratio at 48 hpi (which is not one of the four standard readouts) is shown in green along 
with the four other readouts for this compound only. 
 
Figure 3:  Differentiation inhibitors share common putative targets and 
they selectively inhibit sexual differentiation across a range of concentrations.  A) 
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Putative targets of all the categorized differentiation inhibitors. (*) denotes targets in 
nucleotide biosynthesis pathways and (**) denotes mitochondrial oxidative 
phosphorylation inhibitors. The first nine compounds were selected for follow-up 
experiments due to a large concentration window to enable inhibition of sexual 
differentiation with minimal effect on parasite asexual growth.  B) Simplified 
nucleotide biosynthesis pathway of human cells. Enzyme names are colored and only 
enzymes with putative modulators in our validated hits are shown.  Inhibitors of (*) 
marked enzymes are differentiation inhibitors and others are asexual stage inhibitors.  
Red colored enzymes have identified homologs in the C. parvum genome while the 
blue colored enzymes do not have an identified homolog in the parasite.  PRPP:  5-
phosphoribosyl pyrophosphate; PPAT: phosphoribosyl pyrophosphate 
amidotransferase; GARTFase: Glycinamide Ribonucleotide Formyltransferase; GAR:  
glycinamide ribonucleotide;  IMP:  Inosine monophosphate;  XMP:  Xanthosine 
monophosphate;  DHF:  Dihydrofolate;  DHFR:  Dihydrofolate reductase;  THF:  
tetrahydrofolate;  DHO: dihydroorotate;  DHOD:  dihydroorotate dehydrogenase; 
OMP:  orotidine-5'-monophosphate.  C) Dose response curves of the nine 
differentiation inhibitors selected for follow up.  Compounds were added at 3 hpi and 
imaged at 72 hpi.  Partially overlapping concentration ranges were tested for each of 
them in 2 to 3 biological replicates. Each point and error bar denotes mean and standard 
deviation for readings from 4 separate wells for each concentration in each biological 





Figure 4:  Differentiation inhibitors are required to be added before 
parasite sexual differentiation. A) Experimental setup showing compound addition 
timepoints and measured response. B) Dose response curves showing percent inhibition 
of the proportion of DMC1+ parasites at 72hpi after the addition of differentiation 
inhibitors at indicated timepoints. Each point and error bar denotes mean and standard 
error of the mean from 4 replicate well. 
 
Figure 5:  Treatment with differentiation inhibitors dysregulates a set of 
core genes involved in parasite differentiation.  A) Experimental setup for the pilot 
mRNA-seq experiment. The number of genes dysregulated (fold change ≥2 at a False 
Discovery Rate of  ≤ 0.1) between subsequent timepoints of the experiment are listed.  
B) Experimental setup and the number of dysregulated genes (fold change ≥2 at a False 
Discovery Rate of  ≤ 0.1) with differentiation inhibitor treatments.  C) Percentage of the 
upregulated C. parvum genes in each treatment that is shared by upregulated genes with 
other differentiation inhibitor treatments.  D) Percentage of the downregulated C. 
parvum genes in each treatment that is shared by upregulated genes with other 
differentiation inhibitor treatments.  E) Stage specificity of the genes that are 
dysregulated in ≥5 differentiation inhibitor treatments.   
Transcriptome data was generated from 2 biological replicates for each 
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timepoint and/or treatment, except for 48 hpi control (n=3) and pralatrexate treatment 
(n=1).   
 
Figure 6:  C. parvum sexual differentiation is associated with suppression of 
ribosome formation, which is indicative of a translational repression program. A) 
DAVID functional annotation results for significantly dysregulated genes in ≥5 
treatments, and between asexual and female C. parvum.  Functional annotation 
enrichments with an FDR of ≤0.0001 are included only. Dysregulated genes were 
identified at a 10% false discovery rate (FDR)  B) Heatmap of the average transcript 
per million (TPM) values of ribosomal protein genes of C. parvum at various 
timepoints (control) and in treatments with differentiation inhibitors (48 hpi).  Each row 
represents a single gene encoding a ribosomal protein.  TPM values are Z normalized 
across each row. Hierarchical clustering between the samples using the expression 
values of the ribosomal proteins was performed using the “complete” linkage algorithm 
and Euclidean distance metrics and is shown on the top of the heatmap.  C) The most 
significantly differentially enriched DNA motif in the promoter region of the ribosomal 
protein genes compared to all C. parvum genes. D) Chi-square test of the association 
between the presence of the DNA motif from (C) in the promoter region of commonly 
dysregulated C. parvum genes (excluding ribosomal protein genes) and the direction of 
dysregulation.  E) The location of the DNA motif from (C) in the promoter region of C. 
parvum genes harboring that motif.  Other genes include genes that contain the motif in 
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their promoter region but are not dysregulated with ≥5 differentiation inhibitor 
treatment (fold change ≥1 and FDR ≤ 0.1) and not ribosomal proteins. F) Significant 
enrichment (p-value cutoff ≤ 0.5) of the two specific gene ontology (GO) terms during 
gene ontology enrichment analysis of apicomplexan genes that are dysregulated 
between the listed life cycle stages. Dysregulated genes are defined as genes with a 
log2 fold difference of ≥1 at 10% false discovery rate (FDR).  
 
Figure 7:  Promoters of downregulated genes of C. parvum harbor a 
recognition site for several ApiAP2 transcription factors that are also 
dysregulated by differentiation inhibitor treatments.  A) log2 fold change of four 
ApiAP2 transcription factors of C. parvum with differentiation inhibitor treatments 
when FDR is ≤10%. B) The most significantly differentially enriched DNA motif in the 
promoter region of the genes that are ≥2 fold downregulated in ≥5 compound 
treatments compared to all C. parvum genes.  
 
Figure 8:  A proposed model of repressing C. parvum sexual differentiation 
by the two Methionine aminopeptidase 2 (MetAP2) inhibitors.  Eukaryotic 
translation initiation factor 2α is abbreviated eIF2α.  See the discussion section for 
detailed explanation of the model. 
 
Supplementary Table 1: Structure, categorization, and putative mode of action 
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of all the compounds selected as hits from the primary screening. 
 
Supplementary Table 2: log2 fold changes of parasite genes between different 
treatments and timepoints.  Gene names from the Cryptodb database are included along 
with the gene IDs.  Values are included only if the FDR is below 0.1 in differential 
gene expression analysis by DEseq2. 
 
Supplementary Table 3: DAVID functional annotation enrichment analysis of 
dysregulated genes (fold change ≥2 and FDR ≤ 0.1) with differentiation inhibitor 
treatment. 
 
Supplementary table 4: Eupathdb Gene ontology (GO) enrichment analysis of 
various life cycle stages of different apicomplexan parasites. In total, comparisons for 9 
different axes of differentiation were performed;  5 from Plasmodium, 2 from Eimeria, 
and 1 from Toxoplasma. For each, both upregulated and downregulated genes are 
analyzed separately in “cellular component” and “molecular function”, culminating in a 
total of 36 comparisons.   
 
Supplementary Figure 1: Dose response curves of all the screening hits. 8-
point dose response curves of all the primary screening hits in all 4 readouts.  IDs 
correspond to the compound ids from the first column of Supplementary Table 1.  
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Duplicate curves (marked with “#”) are included for compounds that induce sexual 
differentiation or development in a dose dependent manner at a concentration range that 
is not highly inhibitory to asexual replication. For the duplicate curves, relevant sexual 
stage readouts are excluded for high asexual stage inhibitory concentrations.  IDs 
marked with asterisks (*) are compounds without a determined dose response in one of 
the readouts due to imaging quality error.   
 
Supplementary Figure 2:  Volcano plots of dysregulated genes by AGM-
1470 and Oligomycin A treatment.  C. parvum genes are shown with a circle and host 
genes are shown with a “plus” sign.  Red colored genes are significantly differentially 
regulated and blue colored genes are not significantly differentially regulated.  P-values 
were not calculated for the black colored genes. 
 
Supplementary Figure 3:  C. parvum asexual stage specific genes are 
upregulated and female specific genes are downregulated with differentiation 
inhibitor treatments.  Two Venn diagrams showing the commonality between genes 
dysregulated with ≥5 differentiation inhibitor treatments with that of genes 
differentially regulated between FAC-sorted asexual and female stage parasites.  
  
Supplementary Figure 4: Stage specificity of genes dysregulated by 
differentiation inhibitor treatments.  The top panel shows the number of genes in 
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each class and the number of genes dysregulated by the treatment from that class. The 
bottom panel plots the log2 fold changes of significantly dysregulated (FDR ≤ 0.1) 
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Figure 6:  C. parvum sexual differentiation is associated with suppression of ribosome formation, 
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Figure 8:  A proposed model of repressing C. parvum sexual differentiation by the two Methionine 
















































































































































































Supplementary Figure 3:  C. parvum asexual stage specific genes are upregulated and female 








































Supplementary Figure 4: Stage specificity of genes dysregulated by differentiation inhibitor 
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CHAPTER 3:  DISCUSSION AND FUTURE DIRECTION 
Apicomplexan parasites, other than being huge public health concerns, are 
fascinating biological systems to study cell biology, parasitism, and evolution.  These 
unicellular eukaryotic organisms are obligate intracellular parasites that are capable of 
morphing into distinct phenotypic structures throughout their life cycle.  Epigenetic, 
transcriptional, and translational control of gene expression, undoubtedly shaped by the 
condition of the host cell or organism, are the key to achieving this extraordinary feat.  
In this study, we have used a chemical genomics approach to study the regulation of 
sexual differentiation of the apicomplexan parasite Cryptosporidium parvum.  Our data 
suggest that (i) this differentiation is expectedly associated with large scale changes in 
the parasite transcriptome; (ii) modulating specific pathways of the host affects the 
differentiation process; and (iii) global translational control of protein expression likely 
mediated by altered ribosomal biogenesis plays a key regulatory role in controlling C. 
parvum sexual differentiation, which is perhaps a common mode of regulating stage 
differentiation in apicomplexan parasites. 
 
3.1:  Potential Function and Stage Specificity of the C. parvum DMC1 protein 
We have used the expression of C. parvum DMC1 (Disrupted Meiotic cDNA, 
cgd7_1690) protein as a marker for the parasite sexual stage.  Most eukaryotes have a 
homolog of DMC1 and it is a meiotic recombinase that facilitates homologous 
chromosome pairing during meiotic recombination (1). Rad51, which is also a 
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recombinase, is a paralog of DMC1 that is also present in most eukaryotes, including 
Cryptosporidium.  A gene duplication event during early eukaryotic evolution gave rise 
to the DMC1 and RAD51 recombinase families (2).  Knocking out DMC1 in S. 
cerevisiae arrests its growth at meiotic prophase (3) whereas homozygous DMC1 
knockout mice are sterile (4).  On the other hand, RAD51 knockout is embryonic lethal 
to mice (5).  These and other studies suggest that in most eukaryotes, DMC1 
preferentially functions during meiotic recombination whereas RAD51 takes part in 
both meiotic and mitotic recombination (1).  Previously, using qRT-PCR, we showed 
that DMC1 expression peaks at 72 hours post infection (hpi) and correlates with the 
emergence of gametocytes in the culture, which was the basis of using DMC1 as a 
sexual stage marker (6).  Our time-course mRNA-seq experiment also confirms this 
observation (Figure 1). Interestingly, RAD51 (cgd5_410) expression also peaks at 72 
hpi; however, the level of upregulation from 48 hpi is patently more pronounced for 
DMC1.  
Immunofluorescence microscopy using an anti-DMC1 monoclonal antibody 
identifies DMC1 in uninucleated parasites, strongly suggesting that it is specifically 
expressed in female gamonts (6).  This conclusion is further supported by the 
observation that immunofluorescence staining of oocysts locates DMC1 within the 
oocysts, but outside of the sporozoites (Figure 2).  That is because the female gamont 
containing parasitophorous vacuoles (PV) ultimately differentiate into oocysts 
following fertilization.  We also attempted to perform immunoelectron microscopy of 
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C. parvum infected HCT8 using our anti-DMC1 antibody clone, but failed to localize 
the protein with the method.  Perhaps the reason behind this is that the tertiary structure 
of the DMC1 protein is sensitive to alcohol treatment.  During our initial staining 
optimization, we tested different fixatives for the staining and both ethanol and 
glutaraldehyde fixation resulted in the loss of anti-DMC1 staining. 
Determining parasite stages via alternative methods suggests that the ratio of 
macrogamonts in the HCT8 infection model increases logarithmically between 36 and 
48 hpi (7, 8), but then the ratio is relatively unchanged between 48 and 72 hpi (7).  By 
contrast, the DMC1 mRNA level and DMC1+ parasite number increase dramatically 
between 48 and 72 hpi (Figure 1 and 2).  Our interpretation of these observations is that 
the level of DMC1 protein within female gamonts increases to a detectable level as the 
gamont matures.  Alternatively, it is possible that our specific culture condition delays 
the emergence of female gamonts or the other methods overcalculated female gamonts 
at 48 hpi.  In that case, the low level of staining and the low mRNA level at 48 hpi 
compared to 72 hpi might arise from a lower number of female gamonts present at 48 
hpi instead of the proposed low level of DMC1 expression by female gamonts.  As we 
determined the number of DMC1+ parasites at 72 hpi and the ratio of DMC1+ parasites 
is consistent with the ratio of female gamonts at that timepoint determined by other 
methods, whichever of the above-mentioned explanations is correct does not carry too 
much significance regarding our subsequent conclusions.  However, the implication of 
the first model, that there is a maturation phase of female gamonts that takes around 24 
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hours, is in itself an important potential aspect of Cryptosporidium biology that is 
worthy of further experimentation.  Understanding the requirements and regulations for 
the female gamont maturation might give us clues regarding the basis of failed gamont 
fertilization in the HCT8 infection model. 
Another protein that has recently been used as a macrogamont marker  is 
Cryptosporidium oocyst wall protein-1 (COWP1, cgd6_2090) (7).  Interestingly, its 
expression level is stably maintained after sexual differentiation and does not vary as 
dramatically as DMC1 between 48 hpi and 72 hpi (Figure 1).  Perhaps the COWP1 is a 
marker of female gamont that is independent of its developmental stage, which further 
supports our first model of slow maturation of female gamonts.    
 
3.2:  The Rationale for Focusing on Differentiation Inhibitors for Follow-up 
Experiments 
Dose response dependent validation of the screening hits from the ReFRAME 
library allowed us to classify compounds into several groups.  A major initial goal of 
our screen was to determine if differentiation inhibitors could be used to achieve 
continuous asexual replication of C. parvum within HCT8 cells, which might allow us 
to establish a continuous asexual culture system of Cryptosporidium.  Toward that goal, 
we assayed C. parvum growth after a prolonged incubation of 7 days post infection in 
the presence of the differentiation inhibitors.  While the numbers of parasites observed 
at these late time points were higher for several treatments compared to control (Figure 
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3), we did not observe the maintenance of logarithmic growth that is generally observed 
up to 48 hpi.  Our tentative conclusion from this set of experiments is that the 
differentiation inhibitors might induce additional rounds of asexual replication; 
however, the culture system ultimately becomes unfavorable for continuous parasite 
replication.  Variation of this experimental setup, like testing other concentrations of 
the compounds or adding the compounds multiple times throughout the experiment 
might produce a different outcome.  The reason we did not pursue this further was that 
we also could not successfully subculture parasites from an infected HCT8 monolayer 
to an uninfected monolayer, which in our view is an important prerequisite for the 
development of a continuous culture system.  Instead, we moved forward with utilizing 
differentiation inhibitors as tools to examine the genetic regulation of C. parvum sexual 
differentiation. 
 
3.3:  Potential Follow-up Experiments with Other Compound Classes 
The other classes of compounds were theoretically not compatible with our 
initial goal of establishing a continuous asexual culture.  Therefore, we did not acquire 
representative compounds from other classes for follow up experiments.  However, 
they would be valuable complementary compounds in terms of examining the genetic 
regulation of sexual differentiation.  For example, treatment with differentiation 
inducers might dysregulate parasite genes in the opposite direction from what we have 
observed from the differentiation inhibitor treatments.  We are currently in the process 
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of performing detailed dose response curves for some of the other compound classes.  
After that, we plan to perform mRNA-seq experiments with some of them, analyze the 
gene expression dysregulation pattern, and compare that to the dysregulation pattern of 
differentiation inhibitor treatments. 
 
3.4:  Other Potential Utilities of Differentiation Inhibitors 
Recently, several in vitro culture platforms have been described that support the 
full C. parvum life cycle (9-13).  Establishment of an air liquid interface (ALI) 
condition for mouse intestinal stem cell derived culture produces viable oocysts upon 
infection that can further excyst and cause additional rounds of infection (13).  The ALI 
condition is associated with substantive genetic and metabolic alteration of host cells 
compared to non-ALI condition, which led to the suggestion that the host cells under 
ALI condition provide a better condition for C. parvum growth.  Additionally, small 
molecules can be administered in a defined concentration in this culture system (8, 13).  
Collectively, this platform is superior to test several potential effects of differentiation 
inhibitors on the C. parvum life cycle compared to HCT8 infection model (where the 
life cycle is not completed) or in vivo animal infection (where it is challenging to 
maintain a specific concentration of compounds in the target tissue).  Our initial 
attempts to establish a continuous asexual culture in the HCT8 cells might have failed 
because the host cell became inhospitable for supporting prolonged parasite growth.  
ALI culture can remove that variable and the effect of differentiation inhibitors would 
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be interpreted more clearly.  Also, the druggability of the parasite differentiation 
process can be robustly tested with differentiation inhibitors on the ALI culture.  If any 
of our identified differentiation inhibitors block sexual differentiation in ALI cultures in 
a similar way, inhibition of continuous parasite growth would mean that targeting 
sexual differentiation would be a viable means for treating cryptosporidiosis.  We are 
currently in the process of establishing this culture system in our laboratory. 
 
3.5:  Potential Genetic Validation of The Chemical Genomics Approach 
CRISPR/Cas9 dependent genetic modification of C. parvum was published in 
2015, making the parasite genetically tractable (14).  Currently, there is a single 
validated selectable marker gene. Therefore, genetic modification of multiple loci is not 
possible at this point.  Currently available plasmids are not episomally maintained 
within the parasite, so transgene expression is only possible by integrating them into the 
genome.  Thymidine kinase has been proven to be a non-essential gene in the parasite, 
and this locus has been used to integrate transgenes (13-15).  Codon optimized 
nanoluciferase has been used to detect the transgenic parasites.  Also, several 
fluorescent proteins have been successfully expressed and detected in C. parvum. 
Genetic knockout and allelic exchange using the CRISPR/Cas9 based strategy 
has been successfully demonstrated (14, 16).  Importantly, the generation of transgenic 
clones requires oocyst formation from transfected sporozoites. Therefore, if a protein is 
essential in any of the life cycle stages, there is a high chance that direct knockout of 
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the protein or mutations that affect essential functions of the protein would not be 
possible.  Conditional knockout strategies have yet to be demonstrated for the parasite; 
however, a properly working Cre-loxP system has been demonstrated using two 
parasite lines, one constitutively expressing Cre recombinase and the another harboring 
a floxed site that inhibits expression of a fluorescent gene.  Mating of the two lines 
allowed expression of the fluorescent protein, demonstrating a functional Cre-loxP 
system (7).  This system would only be useful for conditional knockout of genes that 
are essential between zygote formation to oocyst formation, and can only be studied for 
a single generation.  Inducible promoters or tunable protein translation strategies have 
yet to be established.  Conditional knockdown of protein expression strategies would 
likely be appropriate for studying the functions of essential genes.  Several such 
strategies have been successful in the related Plasmodium and Toxoplasma parasites, 
and these approaches have the potential to work with C. parvum also.  For example, the 
integration of a riboswitch at the UTR of a target gene allows inducible knockdown of 
essential Plasmodium genes (17).  Induction of the riboswitch by the exogenous 
administration of the ligand glucosamine results in target mRNA degradation.   
Several implications from our screening and RNA-seq experiments can be 






3.5.1:  eIF2α Phosphorylation Plays a Key Regulatory Role in C. parvum Sexual 
Differentiation 
Based on the putative mode of action of the methionine aminopeptidase 2 
inhibitors, we proposed that phosphorylation of eukaryotic translation initiation factor 
alpha (eIF2α) induces parasite sexual differentiation (Chapter 2, Fig 8).  Cgd7_5270 is 
the annotated eIF2α of C. parvum and sequence alignment with eIF2α from other 
organisms suggests serine 57 is the conserved phosphorylation site.  Allelic exchange 
of the gene to make S57A and S57D mutants, followed by their phenotypic 
characterization, specifically their sexual differentiation efficiency, can potentially be 
tested with the existing genetic tools.  If making one or both constructs become 
challenging (due to being potentially lethal mutation), the WT and mutated genes can 
be expressed as a second copy by integrating them in a nonessential locus of the 
parasite genome.  If possible, the inducible expression of such constructs should be 
attempted.  The expression pattern of proteins involved in ribosome biogenesis or 
structure in eIF2α mutant parasites could potentially elucidate the proposed link 
between translational repression and downregulation of ribosome biogenesis.  
Knocking out C. parvum MetAP2 (cgd2_2480) followed by testing the sexual 
differentiation phenotype would be a good strategy to validate the mode of action of the 
MetAP2 inhibitors.  The N-terminal lysine-rich domain of the mammalian MetAP2 has 
been implicated in the protection of eIF2α from inhibitory phosphorylation (18).  A 
similar poly-lysine stretch is present in cgd2_2480.  Therefore, substituting the native 
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locus with an N-terminal truncated version of MetAP2, which might be a more tolerant 
genetic modification, could also be used to address the same research question. 
3.5.2:  ApiAP2 Transcription Factors Regulate C. parvum Sexual Differentiation 
The expression of several ApiAP2 transcription factors (TFs) was dysregulated 
with multiple differentiation inhibitor treatments.  cgd2_2670 is the only ApiAP2 TF 
that is highly downregulated with all of the differentiation inhibitor treatments (Chapter 
2, Supplementary Table 3).  Among others, the putative binding sites of cgd2_3490 and 
cgd8_3230 are significantly enriched in the promoter regions of the downregulated 
genes.  Each of these three TFs would potentially be interesting genetic knockout or 
inducible knockdown targets.  Also, tagging these proteins with fluorescent proteins or 
epitope tags could be useful to validate their expression pattern through the parasite 
lifecycle.  Alternatively fluorescent proteins could be expressed under the promoters of 
these genes.  Among the various utilities of epitope tagging, CHIP-seq using anti-tag 
antibodies could be used to determine the regulome of these TFs.    
3.5.3:  C.  parum DMC1 is a Female Specific Protein Involved in Meiotic Cell 
Division of the Zygotes 
Analyzing the expression pattern of DMC1 with high temporal resolution would 
help in determining the development kinetics of macrogamonts.  This could be done 
more comprehensively by live fluorescent imaging compared to staining fixed cells at 
different time points.  Toward that goal, florescent tagging of the DMC1 protein or 
expressing fluorescent proteins under the DMC1 promoter could be attempted.  If 
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successful, such parasite clones would also be useful in tracking sexual differentiation 
in the ALI culture system or animal model infections and serve as a complementary 
parasite clone to the already described COWP1-tdTomato parasite clone generated for a 
similar purpose (7).  As the DMC1 protein supposedly functions post-fertilization 
during sporulation, the Cre-loxP based conditional knockout strategy could be applied 
for conditional knockout of DMC1.  Complete or conditional knockout of the protein 
would help in its functional characterization.  Specifically, it would be interesting to 
check whether RAD51 can cover for the loss of the DMC1 function.  
 
3.6:  Concluding Remarks 
The dogmatic view about the Cryptosporidium life cycle is that sexual 
differentiation is an obligatory process.  Classically, this view has been established 
from electron microscopy-based observations of in vivo infection as well as in vitro 
infection models where gametocytes emerge after a certain period following infection 
(19-21).  Recently, life cycle stage typing using alternative methods also showed that in 
the HCT8 infection model gametocytes are the predominant parasite population at the 
later stage of the infection (6-8).  In the ALI culture system, it has been reported that 
oocysts are produced in waves that are separated by time intervals when parasites 
potentially reset the infection cycle (13).  A similar fixed number of asexual replication 
cycles has been also proposed for Eimeria, which most commonly undergo three 
rounds of asexual replication before sexual differentiation (22).  This obligate sexual 
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differentiation model is fundamentally different from the two other well studied 
Apicomplexa, Plasmodium and Toxoplasma (23).  In Plasmodium, a subset of the 
asexually replicating parasite population undergoes sexual differentiation, whereas 
Toxoplasma sexual differentiation only takes place within the definitive host, cats.  
Potential environmental cues for sexual differentiation have also been characterized for 
P. falciparum and T. gondii (24, 25).  The implication of the defined number of asexual 
replication cycles in Cryptosporidium and Eimeria is that a genetic program can sense 
the number of asexual replications that the parasite has undergone at any given 
moment; however, molecular charecterization of such a sensory mechanism remains 
elusive.  Alternatively, it is possible that some kind of environmental cue actually 
induces the differentiation process in Cryptosporidium and Eimeria, and that 
environmental cue reaches a threshold around the time the parasites complete the 
defined number of replication cycles.  Conceptually, such an environmental cue could 
be a parasite generated quorum sensing molecule or depletion/fortification of a host 
factor.  An in-depth mechanistic understanding of the regulation of C. parvum sexual 
differentiation would shed light on this interesting unanswered question about C. 
parvum biology. 
In this study, we deduced from our RNA-seq analysis that ribosome formation 
is downregulated during C. parvum sexual differentiation and coupled this insight with 
the putative mode of action of the MetAP2 inhibitors.  Another interesting insight that 
is supported both by our RNA-seq data and the putative identities of the targets of 
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several differentiation inhibitors is that the sexual stage of the parasite is a more 
energy-demanding stage compared to the asexual stages.  The RNA-seq data supports 
this theory as it suggests that glycolysis is upregulated following sexual differentiation, 
which is the most critical energy producing pathway for the parasite in the absence of a 
fully functional mitochondrion.  It is proposed from other studies that Cryptosporidium 
uptake energy equivalents from the host cells directly in the form of purine nucleotides.  
Therefore, our theory of increased energy demand in the sexual stage is also supported 
by the observation that inhibitiors of host cell oxidative phosphorylation and purine 
nucleoide biosynthesis, two pathways involved in producing the energy molecules that 
Cryptosporidium can steal from the host, also disproportionaltely affect the sexual 
stages of the parasite more.  Targeted genetic experiments are needed to test the 









Figure 1:  Expression time course of selected genes.   
Transcript per million (TPM) values of DMC1, RAD51 and COWP1 mRNAs at 
different time-points post infection.  Each point represents a biological replicate of 



















Figure 2:  C. parvum oocysts stained with anti DMC1 antibody.   
DMC1 protein is localized to the inner wall of C. parvum oocysts and is stained only 













Figure 3:  Parasite numbers after 7 days post infection with differentiation inhibitor treatments.   
(Top) Dose response curves of total parasite and DMC1+ parasite percent inhibition 
compared to control, determined from drug addition at 3 hpi and imaging at 72 hpi.  
Concentrations selected for prolonged (7 days) assays are indicated by the dotted 
vertical lines.  (Bottom) Three differentiation inhibitors were added to C. parvum 
infected HCT8 culture at 3 hours post infection at indicated concentrations.  Wells were 
fixed and imaged at 7 days post infection.  Vicia villosa lectin (VVL) was used to count 
parasite number and Hoechst staining was used to count host cell nuclei number.  Each 
point indicates data from replicate wells.     
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